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ABSTRACT 
Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique 
that is growing in acceptance by the medical community and the general public. TMS was 
approved by the U.S. Food and Drug Administration (FDA) for treating major depressive 
disorder (MDD) in 2008, certain types of migraine headaches in 2013, and obsessive compulsive 
disorder (OCD) in 2018. Researchers are also investigating how TMS can be used for enhancing 
the recovery of motor functions after a stroke as well as other debilitating illnesses. Investigating 
the biological mechanisms involved in the brain’s response to TMS is a growing area of study. 
Of the many challenges for researchers to overcome, are the ethical and safety standards that 
prevent the testing of new TMS devices and protocols on human subjects. To overcome these, 
researchers have two types of models that are used to recreate the brain and its components for 
TMS research. Computer models are used to simulate the neurological system’s responses to the 
magnetic fields generated during TMS. They are used to simulate the effects of new coil designs 
and stimulation protocols on different types of head models (i.e., a healthy brain versus a brain 
damaged by head trauma).  Biological models use cell lines developed from animals that recreate 
the aspects of cells in the human brain that are affected by TMS. 
The research presented in this thesis shows the experimental results using both types of 
models to investigate the underlying mechanisms of TMS. A computer model was used to 
investigate the effects of brain-scalp distance of healthy subjects on the response to a novel TMS 
coil design. Two types of biological models were used to investigate, at the cellular level, the 
effects of magnetic fields generated by a commercial TMS system on neuronal cells in vitro.
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CHAPTER 1.    GENERAL INTRODUCTION 
The major principle underlying Transcranial Magnetic Stimulation (TMS) is Faraday's 
Law of electromagnetic induction. Whereby the time-varying magnetic field (B) generated by a 
TMS coil induces an electric field (E) in the brain. The induced E field, at sufficient strength, 
causes neurons to fire in a process known as depolarization. The effect of TMS fields on the 
brain as a system, and at the cellular level, have received considerable attention by the research 
community, yet there is still much to be learned about these processes. 
One of the challenges in the development of TMS therapy is the ability to deliver a 
focused magnetic field to a specific region in the brain. In the process of delivering a sufficiently 
strong magnetic field (H) to the target region, surrounding areas of the brain can be stimulated 
unnecessarily. Stimulating non-target areas can result in side effects ranging from mild 
discomfort such as tingling sensations in the scalp, headaches, neck pain, and tooth pain to more 
adverse side effects such as fainting, and seizures. The Quadruple Butterfly Coil (QBC) is a 
novel design TMS coil that significantly increases the focality of the magnetic field compared to 
the figure-of-eight (FoE) coil most commonly used in TMS therapy and research today. Focality 
is measured using the V-Half metric (the volume of the brain exposed to at least one-half of the 
maximum induced electric field intensity (EMAX)). The QBC generates a sufficiently high E field 
intensity in order to trigger neuronal depolarization, while stimulating a significantly lower total 
brain volume than the FoE coil. Multiple studies have shown a direct correlation between the 
brain-scalp distance (BSD) and the brain’s response to the magnetic pulse generated during 
TMS.  If the stimulator output is increased to adjust for the increased BSD, there will be an 
increase in the H field stimulating non-target areas. This might result in a larger total volume of 
tissue receiving stimulation, which increases the possibility of side effects. The need for 
2 
increased H field strength along with the reduced focality as the BSD increases can significantly 
reduce the efficacy of TMS therapy as well as increasing patient discomfort. In order to 
investigate how the BSD may affect the brain’s response to the QBC in comparison to that of the 
FoE coil, computer models using finite element analysis (FEA) were used to run simulations on 
head models created from MRI scans of healthy individuals. 
Much of the biomedical research into the causes of, and treatments for, 
neurodegenerative diseases (ND) such as Alzheimer’s Disease (AD) and Parkinson’s Disease 
(PD) is performed using cell lines from animals that model the behavior of cells in the human 
brain. Two well-established animal neuronal cell lines used for ND research are the PC-12 and 
N27 cell lines. The goal of the biological modeling part of the research was to investigate the 
effects of pulsed magnetic fields of the same type and intensity that cells in the brain experience 
during in vivo TMS sessions on the PC-12 and N27 biological models. Multiple experiments 
were designed and conducted to investigate the effects of the magnetic fields generated during 
TMS on these two models. The trials were designed to measure different characteristics of the 
cells after receiving a predetermined number of pulses from a commercially available 
monophasic TMS stimulator. Experiments were conducted to measure proliferation rates, and 
morphology of both cell models after receiving TMS. An investigation was made into the role 
that the structural growth environment called the extracellular matrix (ECM) may play in the 
N27 cells’ response to TMS. Trials were conducted to measure the effects of different H field 
intensities on the N27 cells’ proliferation rate and morphology. Additionally, experiments 
designed to measure the effects of TMS on neurite growth on PC-12 cells were conducted. 
Aspects of the neurite growth such as the direction of growth, number of neurites per cell, neurite 
length, and number of branches per neurite were investigated. 
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Abstract 
Transcranial Magnetic Stimulation (TMS) is a neuromodulation technique that non-
invasively depolarizes neurons in the brain. During TMS, a pulse (or multiple pulses) of a time-
varying magnetic field (H) is delivered to the brain using specialized coils. The Quadruple 
Butterfly Coil (QBC) is a novel coil design that shows increased focality of the induced electric 
field over that of the standard figure-of-eight (FoE) coil. Using 50 different head models created 
from MRI scans of healthy individuals, our research investigated the role that brain-scalp 
distance (BSD) plays in the brain’s response to the magnetic fields generated by the QBC and 
FoE. The variability of BSD is an inherent characteristic in the human population. As the BSD 
increases, so does the distance between the brain and TMS coil. Therefore, the anatomical 
variation of BSD is an independent variable that may play a significant role in the intensity of the 
induced electric field produced in the brain. Our results show no significant difference of the 
QBC’s focality to that of the FoE with respect to BSD. 
Introduction 
Transcranial Magnetic Stimulation (TMS) is a neuromodulation technique which is 
capable of non-invasively activating neurons in the brain. During TMS, a pulse (or multiple 
pulses) of a time-varying magnetic field (H) is delivered to the brain. The magnetic field induces 
an electric field (E) in the brain which, at sufficient levels, causes neurons to depolarize [1]. The 
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U.S. Food and Drug Administration (FDA) approved TMS for treating major depressive disorder 
(MDD) in 2008, certain types of migraine headaches in 2013, and obsessive compulsive disorder 
(OCD) in 2018 [2]. Among other indications, TMS is being considered as viable therapy for 
post-traumatic stress disorder (PTSD) [3] as well as Parkinson’s Disease (PD) [4]. In the future, 
TMS may become an alternative to deep brain stimulation (DBS). An inherent risk in DBS arises 
from neurosurgical implantation of stimulation electrodes into the brain. The risk involved with 
neurosurgery has brought TMS into consideration as a viable alternative to DBS for treatment of 
essential tremor, dystonia, PD, and a wider range of clinical depression [5]. 
One of the challenges in the development of TMS therapy is the ability to deliver a 
focused magnetic field to a specific targeted region in the brain. In the process of delivering a 
sufficiently strong H field to the targeted region, surrounding areas of the brain can be stimulated 
unnecessarily. Stimulating non-target areas can result in side effects ranging from mild 
discomfort such as tingling sensations in the scalp, headaches, neck pain, and tooth pain to more 
adverse side effects such as fainting, and seizures [6]. The figure-of-eight (FoE) TMS coil was 
developed in 1988 by Ueno et al. [7] and has become the most commonly used coil for TMS 
therapy and research [6]. The Quadruple Butterfly Coil (QBC) is a novel design TMS coil 
developed by Rastogi [8] that significantly increases the focality of the magnetic field compared 
to the FoE coil. The QBC generates a sufficiently high E field intensity in order to trigger 
neuronal depolarization, while stimulating a significantly lower total brain volume than the FoE 
coil. The reduction of brain volume (defined as the total volume of grey matter and white matter) 
exposed to high E field intensities is by 11% when comparing the QBC with the FoE coil. 
Focality is measured using the V-Half metric (the volume of the brain exposed to at least one-
half of the maximum induced electric field intensity (EMAX) in the brain). 
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Multiple studies have shown a direct correlation between the brain-scalp distance (BSD) 
and the brain’s response to the magnetic pulse generated during TMS [9], [10]. One study 
showed that a 3% increase in TMS output is necessary to elicit the same response for every 
millimeter increase in distance between the coil and the target within the brain [11]. If the 
stimulator output is increased to adjust for the increased BSD, there will be an increase in the H 
field passing through the tissue to reach the target site. This might result in a larger total volume 
of tissue unnecessarily receiving stimulation. This, in turn, increases the possibility of 
stimulating non-target areas which will increase the occurrences of side effects, and reduce 
focality [11]. The need for increased H field strength along with the reduced focality as the BSD 
increases can significantly reduce the efficacy of TMS therapy as well as increasing patient 
discomfort. 
The goal of our research is to investigate the effects of the BSD on the performance of 
the QBC in comparison to that of the FoE. 
Computer Simulations 
The QBC was modeled, and finite element (FE) simulations were run, using Sim4Life 
software [12] on head models derived from Magnetic Resonance Imaging (MRI) scans of 50 
healthy subjects. The Sim4Life software is a low frequency magneto-quasi-static solver that uses 
the FE method to compute the magnetic field and induced electric field within the head models. 
The QBC coil configuration, shown in Fig. 1, consists of two coil groups: a large set of coils and 
a small set of coils. The large coils have the same dimension as the FoE coil (a diameter of 95 
mm) and the small coils have dimension of 40% the size of the large coils. These two sets of 
coils have the same number of turns (9 on both sides of each set which  makes for 36 turns in 
total) and make a right angle with one another. 
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Fig. 1. Three different views of the Quadruple Butterfly Coil. 
The QBC was placed at a distance of 5 mm from the vertex of each head model. This 
distance accounted for the insulation of the QBC, as seen in Fig. 2. The coil was pulsed at a 
frequency of 2.5 kHz and a current with an amplitude of 5 kA. A total of 50 simulations were run 
with the coil. 
The BSD is obtained in the Sim4Life software using the integrated measuring tool. This 
distance is taken as the vertical distance from the vertex (origin 0,0,0) to the highest point on the 
grey matter. However, due to the uniqueness of each head model and the gyri on the right and 
left hemisphere, the grey matter may not always be on the same level. Fig. 2 shows the FE 
simulation setup in the Sim4Life software, with the grey matter in place. The vertical distance 
from the vertex is then measured perpendicularly to the connecting line of the brain lobes and 
taken as the BSD. The connecting line was established by selecting the highest point (peak) of 
each lobe and connecting them with a straight line. 
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Fig. 2. Representative images of the FE simulation model in the Sim4Life software. Frontal view (a) and 
right hemisphere view (b) of the head model, Quadruple Butterfly Coil, and grey matter. 
The green dots (enlarged for clarity), in Fig. 2, are the peaks of each hemisphere of the 
grey matter. The straight lines (enlarged for clarity) in the same figure represent the vertical 
distance drawn perpendicularly downward from the vertex, and the line connecting each lobe. 
The 50 MRI scans of healthy subjects with ages ranging from 25-35 years were sourced from the 
Human Connectome Project Model Library [13] and developed using the SimNIBS pipeline by 
Lee et al. [14]. Each head model had seven different anatomical structures which included the 
skin (sn), skull (sk), cerebrospinal fluid (csf), grey matter (gm), white matter (wm), cerebellum 
(cb), and ventricles (vc), as shown in Fig 3. 
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Fig. 3. The seven different anatomic variations (with the edges of their voxel shown) are (a) skin (sn), (b) 
skull (sk), (c) cerebrospinal fluid (csf), (d) grey matter (gm), (e) white matter (wm), (f) cerebellum (cb), 
and (g) ventricles (vc). 
The electrical properties of the anatomical structures, used in the FE simulations, were 
sourced from the Information Technologies in Society (IT’IS) foundation database [15] and are 
defined in Table I. The computed EMAX (i.e., maximum induced electric field) values were 
extracted and exported to MATLAB [16] for post processing and interpretation. 
Table 1. Electrical Properties of Anatomical Structures at a Frequency of 2.5 kHz 
Structure Name Relative Permittivity Electrical Conductivity (S/m) 
Skin (sn)       1140 0.0002 
Skull (sk)       1440 0.0203 
Cerebrospinal fluid (csf)       109 2 
Grey matter (gm)       78100 0.104 
White matter (wm)       34300 0.0645 
Cerebellum (cb)       78400 0.124 




The EMAX was extracted from the FE simulations for each of the 50 head models. Fig. 4 
shows the color map of the induced electric field on the skin and the grey matter, respectively, of 
one of the head models. A maximum induced value of 210 V/m was observed on the skin while a 
maximum value of 101 V/m was observed on the grey matter. 
 
Fig. 4. Induced electric field in skin (top) and grey matter (bottom) from one of the head models. 
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A box plot showing the characteristic distribution of the EMAX values, across the 50 head 
models on the basis of the minimum, maximum, median, first quartile, and third quartile, is 
presented in Fig. 5. 
 
Fig. 5. Box plot shows the distribution of the maximum induced electric field, for the 50 head models. 
The maximum and minimum values of EMAX, among the 50 head models, was calculated 
as 343 V/m and 79 V/m respectively. The average EMAX and standard deviation value, across the 
50 head models, was calculated as 144 V/m and 41 V/m respectively. 
A graph showing the variation of EMAX with the BSD for both the QBC and FoE coil is 
presented in Fig. 6. Our results show that the EMAX generated by both the QBC and FoE coil 
decreases as the BSD increases, with an R-squared value of 0.4293 for the QBC and an R-
squared value of 0.4141 for the FoE coil. These results agree with the conclusions of Lee et al. 
[16] that used a FoE coil on the same set of 50 head models and also used the same FE 
simulation parameters as our study. 
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Fig. 6. Comparison between the maximum induced electric field (EMAX) versus brain-scalp distance for 
50 head models, using the Quadruple Butterfly Coil and Figure-of-Eight Coil. 
 
A graph showing the variation of V-Half versus the BSD for both the QBC and FoE coil 
is presented in Fig. 7. Our results show that the V-Half stimulated by the QBC and FoE coil 
shows no significant statistical correlation with the increasing BSD. The R-squared values are 
0.0899 for the QBC and 0.0351 for the FoE coil. These results are also in good agreement with 
the conclusions of Lee et al. [16] that used a FoE coil on the same set of 50 head models with the 
same FE simulation parameters as our study. 
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Fig. 7. Stimulated Volume versus brain-scalp distance for 50 head models using the Quadruple Butterfly 
Coil. 
Conclusion 
The variability of BSD plays a role in the brain’s response to TMS. With our study, we 
conclude that the EMAX in the brain induced by the QBC decreases with BSD. This confirms that, 
without regards to the coil configuration, the BSD has a significant effect on EMAX. However, 
there is no significant correlation between BSD and the V-Half (the metric for focality). 
We used MRI scans of healthy subjects ranging in age from 25-35 years in our study. To 
further investigate the role of BSD in TMS, we intend to conduct further simulations using MRI 
scans from unhealthy adults and older generational cohorts, since BSD has been found to 
increase with age [16]. 
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Abstract 
Transcranial magnetic stimulation (TMS) is a noninvasive neuromodulation technique, an 
FDA-approved treatment method for various neurological disorders such as depressive disorder, 
Parkinson’s disease, post-traumatic stress disorder, and migraine. However, information 
concerning the molecular/cellular-level mechanisms of neurons under magnetic simulation (MS), 
particularly at the single neural cell level, is still lacking, resulting in very little knowledge of the 
effects of MS on neural cells. In this paper, the effects of MS on the behaviors of neural cell N27 
at the single-cell level on coverslip glass substrate and anodic aluminum oxide (AAO) 
nanoporous substrate are reported for the first time. First, it has been found that the MS has a 
negligible cytotoxic effect on N27 cells. Second, MS decreases nuclear localization of paxillin, a 
focal adhesion protein that is known to enter the nucleus and modulate transcription. Third, the 
effect of MS on N27 cells can be clearly observed over 24 h, the duration of one cell cycle, after 
MS is applied to the cells. The size of cells under MS was found to be statistically smaller than 
that of cells without MS after one cell cycle. Furthermore, directly monitoring cell division 
process in the microholders on a chip revealed that the cells under MS generated statistically 
more daughter cells in one average cell cycle time than those without MS. All these results 
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indicate that MS can affect the behavior of N27 cells, promoting their proliferation and 
regeneration. 
Introduction 
Transcranial magnetic stimulation (TMS) is a noninvasive neuromodulation technique 
that uses time-varying short pulses of magnetic fields to induce an electric field in the conductive 
tissues of the brain, thus modulating the synaptic transmission of neurons. This neuromodulation 
technique can be used to excite or inhibit the firing rate of neurons as a treatment for various 
neurological disorders such as major depressive disorder, Parkinson’s disease, post-traumatic 
stress disorder, and migraine.1,2 While the effect of magnetic stimulation (MS) on other types of 
cells and biomolecules in vitro has been studied in the past,3−7 information concerning the 
molecular/cellular mechanisms of neurons under MS, particularly at the single neural cell level, 
is still lacking. The effects of MS on single neural cells need to be thoroughly understood in 
order for experts to make the greatest use of MS as a neuromodulation tool for treating 
neurological disorders, especially those originating from the subcortical regions of the brain. To 
study the behaviors of single neural cells in vitro, a solid substrate or scaffold is usually needed 
for the cell’s proper adhesion, spreading, and growth.8 It is particularly desirable to create a 
substrate or scaffold mimicking the native extracellular environment that can interface with 
individual neural cells within living tissues and in cell culture. As previous studies have 
demonstrated, substrates or scaffolds with nanoscale features (i.e., nanostructured biointerfaces) 
have greatly improved specificity and accuracy for many neural-engineering applications,9−11 
including neural probes for Parkinson’s patients and guidance scaffolds for axonal regeneration 
in patients with traumatic nerve injuries,12,13 just to name a few. Hence, nanostructured 
biointerfaces have become a rapidly emerging area of study. For instance, over the past decades, 
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which have witnessed the development of nanotechnology and nanomaterial that is safe for 
biological applications, interfaces between a variety of nanomaterials or nanostructures with 
biomolecules have been studied.14 Examples of nanobiointerfaces include the interface of the 
nanoparticle−lipid bilayer,15 the interface of carbon nanotubes (CNTs)−biomolecules,16 and the 
interface of graphene−biomolecules.17 The studies of nanobiointerfaces primarily aim to 
understand the dynamic physicochemical interactions, kinetics, and thermodynamics between 
nanomaterial surfaces and the surfaces of biological components, which include, for example, 
proteins, membranes, phospholipids, endocytic vesicles, organelles, DNA, and biological fluids. 
One widely used nanostructured material is anodic aluminum oxide (AAO). The unique 
properties of nanoporous AAO thin film have greatly contributed to the development of a variety 
of novel biomedical applications, ranging from biofiltration membranes, lipid bilayer support 
structures, biosensing devices, and implant coatings to drug delivery systems with AAO capsules 
and scaffolds for tissue engineering.18−24 Additionally, nanoporous AAO membranes have 
generated increasing interest and shown great promise as cell-interface substrates for manifold 
cell types.24 Parkinson’s disease (PD), the second most common neurodegenerative disorder after 
Alzheimer’s disease (AD),25 is caused by the death of dopaminergic neurons in the substantia 
nigra. N27 neural cells have been widely used for their dopaminergic properties as an in vitro 
model of PD.26 In addition, they have been extensively used for studies of neurotoxicity, 
oxidative stress, neurodegeneration, and other molecular pathways.27,28 The effects of MS on 
their functions are currently unknown. Previously, we have found the MS stimulates N27 cells 
proliferation in a population-based assay.29,30 However, we did not analyze single cells behavior, 
nor did we assess other cell functions that modulate proliferation such as cytoskeletal structure or 
adhesion. In this paper, an AAO nanoporous surface is used as one of the substrates to study the 
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behavior of N27 neural cells under MS. The effects of MS on the single-cell level spreading, 
cytoskeletal structure, adhesion, and proliferation on a glass surface and an AAO nanoporous 
surface are reported for the first time. 
Materials and Methods 
Materials 
(1) The experiments use neural cell N27 (Millipore Sigma), which stands for 
immortalized rat mesencephalic cells (1RB3AN27). The following chemicals are used for 
culturing the N27 neural cell: RPMI-1640 medium (Sigma-Aldrich) supplemented with 10% 
fetal bovine serum (Sigma-Aldrich); 1% L-glutamine (Sigma-Aldrich); penicillin with a 
concentration of 100 U/mL (Sigma-Aldrich); streptomycin in 100 U/mL (Sigma-Aldrich). (2) 
Fluorophores, calcein AM (Sigma-Aldrich), and propidium iodide (Sigma-Aldrich) are used for 
monitoring cell viability using a fluorescence microscope (Olympus, Inc.). (3) Scanning electron 
microscopy (SEM) is used to image the neuron cell growth on different substrates. Standard PBS 
(Sigma-Aldrich), 4% paraformaldehyde in a 0.1 M PO4 buffer (Sigma-Aldrich), ethanol >99% 
(Sigma-Aldrich), and hexamethyldisilazane (HMDS) >99% (Sigma-Aldrich) are used for sample 
pretreatment before SEM imaging. (4) Aluminum pellets with a purity of 99.999% (Iamaterials, 
Inc.), titanium pellets with a purity of 99.995% (Iamaterials, Inc.), and SU-8 3025 (Microchem, 
Inc.) are used to fabricate microholder chips. 
Substrates for the Studies of Viability and Behaviors of Neuron Cells N27 
Different surfaces/substrates were prepared for studying neuron cell growth: standard 
coverslip glass (Thermo Fisher Scientific, Inc.), AAO substrates fabricated by a one-step 
anodization process, and AAO substrates fabricated by a two-step anodization process. The 
procedure for preparing the AAO substrates is described in detail in our previous work.31 Briefly, 
after a layer of Al is deposited on a glass substrate, a one-step anodization process is carried out 
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to convert the Al into a nanoporous AAO thin film. An SEM image of the AAO substrates 
fabricated by the one-step anodization process is shown in Figure 1a. The two-step anodization 
process begins with 10 min of anodizing the Al layer in 0.3 M oxalic acid. Then the samples are 
etched with a mixture of phosphoric acid (0.4 M) and chromic acid (0.2 M) at 65 °C for 30 min, 
followed by a 40 min two-step anodization in 0.3 M oxalic acid with the same experimental 
condition as the one-step anodization. An SEM image of the AAO substrates fabricated by the 
two-step anodization process is shown in Figure 1b. The average nanopore diameter of the one-
step AAO substrates (AAO-substrate1) is ∼20 nm, and its average porosity is 6.6%. The two-
step AAO substrates (AAO-substrate2) have an average diameter of ∼80 nm and an average 
porosity of 84.11%. As shown, the nanopore size and porosity of the AAO-substrate2 are larger 
and more uniform than those of AAO-substrate1. The two AAO substrates therefore have 
differently nanostructured topological surfaces. 
 
Figure 1. SEM images of (a) AAO-substrate1: nanopore diameter = 20 nm, porosity = 6.6%. (b) AAO-
substrate2: nanopore diameter = 100 nm, porosity = 84.11%. (c) A photo of microholders on-chip and the 
close-up optical micrographs of arrayed SU8 microholders and the captured single neural cell N27. 
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Arrayed SU8 Microholder Chip for Studying the Viability and Growth of Single Neural 
Cell N27 
Two types of SU8 microholder chips have been designed and fabricated. One type 
consists of arrayed microholders embedded with glass surfaces; the other type consists of arrayed 
microholders embedded with nanoporous AAO surfaces. The fabrication processes flow for the 
SU8 microholder chip with an AAO nanoporous surface (AAO microchip) and for the SU8 
microholder chip with a glass surface (glass microchip) are described in Figure S1 (Appendix. 
Supporting Information). Figure 1c shows a photo of an SU8 microholder chip and the close-up 
optical micrographs of the microholders. 
Substrate Cleaning, Cell Synchronization, Cell Seeding, and SEM Imaging 
Sterilization 
Both AAO nanoporous substrates and glass substrates are cleaned for 5 min with DI 
water using the ultrasonicator (Branson 1510-Fisher Scientific), and sterilization of these 
substrates is achieved by cleaning them with acetone and methanol with the ultrasonicator for 5 
min in sequence. The substrates are then cleaned with DI water by ultrasonicating for 5 min and 
dried by a nitrogen gun, followed by air plasma cleaning (Harrick plasma-PCD 32G) for 3 min. 
Finally, they are baked for 5 min on a hot plate at 150 °C before use. 
Cell Synchronization 
In general, cells in a culture will exist in different stages within the cell cycle at any one 
moment. The biospecific differences of each cell make it difficult to remain synchronized over 
long times.32 To obtain statistically accurate results of the effect of MS on the cell division 
process for a large number of cells, cell synchronization, a process that brings cells at different 
stages of the cell cycle to the same phase, must be implemented. To this end, a simple serum 
deprivation method is used by changing the percentage of fetal bovine serum from 10% to 1% in 
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the cell culture medium.32,33 Specifically, the medium of 10% fetal bovine serum is replaced with 
1% fetal bovine serum 9 h before the cells are seeded into the microholders. A 9 h serum 
deprivation time was chosen for this study for a number of reasons. First, cell mortality was 
considered. Because the serum contains essential components for cell growth, cell death 
increases with the serum deprivation time. On the basis of our experiments, a 9 h serum 
deprivation does not cause substantial cell death. This 9 h synchronization period ensures that 
most of the cells have been synchronized at the G1 phase, the first of four phases of the cell cycle 
that takes place in eukaryotic cell division.33 
Cell Seeding 
Trypsin is used to detach the cells from the bottom of the flask before the cells are seeded 
on different substrates. After 2 or 3 min, we pipet a normal medium with 10% fetal bovine serum 
to the flask. Then the cells are ready to be seeded to the microholder devices. 
Fixing and Staining Cells 
Cells are plated on either AAO-substrate2 or glass microscope slides in 10% fetal bovine 
serum media as described above and fixed and stained for F-actin and paxillin with the following 
protocol. Cells are fixed in 4% paraformaldehyde (Fisher Scientific) w/v dissolved in 
cytoskeleton buffer at 37 °C for 15 min. Cytoskeleton buffer is a solution containing 10 mM 
MES (Sigma-Aldrich), 3 mM MgCl2 (Fisher Scientific), 138 mM KCl (Fisher Scientific), and 2 
mM ethylene glycol-bis (β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) (Sigma-
Aldrich) at pH = 6.1. Cells are permeabilized with a 0.5% triton X solution for 5 min. The 
samples are then treated with 0.1 M glycine (Fisher Scientific) for 10 min. Both glycine and 
triton X solutions are prepared in the cytoskeleton buffer. After glycine treatment, cells are 
washed with Tris-buffered saline (TBS) containing 150 mM NaCl (Fisher Scientific) and 20 mM 
Tris-Cl (Fisher Scientific) at pH = 7.4 multiple times. Blocking and F-actin staining is conducted 
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simultaneously. The blocking buffer is made with TBS, 0.1% v/v tween-20 (Fisher Scientific), 
and 2% w/v bovine serum albumin (BSA) (Sigma-Aldrich). A 1:200 dilution of alexa 488-
phalloidin (Molecular Probes) was added to the blocking buffer. The samples are incubated for 1 
h at room temperature and are protected from light. After incubation, the cells are washed in TBS 
multiple times. Cells are then incubated with purified mouse antipaxillin antibody (BD 
Transduction Laboratories, clone 349) in blocking buffer at 1:200 ratio for an hour at room 
temperature and protected from light, followed by washing in TBS multiple times. Then the cells 
are incubated with donkey anti-mouse Cy3 conjugated antibody (Jackson Immuno Research 
Laboratories) in blocking buffer at 1:200 ratio for an hour at room temperature and light 
protected conditions. Further, the samples are washed in TBS multiple times. Mounting media 
solution consists of 75% v/v glycerol and 20 mM Tris solution at pH = 8. The samples are 
inverted onto mounting media on number 1.5 coverslips and sealed with nail polish. 
Imaging Cells 
Fluorescence imaging is conducted on a fluorescence microscope (Olympus, Inc.) which 
includes the following filter sets: FITC (excitation filter: 460−495 nm; barrier filter: 500−540 
nm); TRITC (excitation filter: 545−565 nm; barrier filter: 580−620 nm). Images are captured 
through a 40× objective. Exposure times are kept constant for a particular fluorophore (alexa 488 
or Cy3). Twenty images from each condition are captured. 
Focal Adhesion Analysis 
Analysis is conducted using ImageJ (National Institutes of Health). The F-actin images 
are thresholded and used to specify the outline of the cell for both F-actin and paxillin 
 images. The paxillin image is thresholded differently to specify the outline of the nucleus. 
Whole cell F-actin and paxillin and nuclear average intensity is background subtracted. Cytosolic 
paxillin intensity is calculated from the integrated whole cell paxillin intensity less the integrated 
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nuclear intensity divided by the whole cell area less the nuclear area. Peripheral and central focal 
adhesions are manually counted. Binucleated cells are identified as nuclei that could not be 
segmented using a threshold to find the nuclear outline. 
Cell Labeling with Fluorophores and Fluorescence Imaging for Live/Dead Assay 
To carry out the live/dead assay and monitor cell viability, we label the cells with 
fluorophores calcein AM and propidium iodide, using a concentration of 2 μM. Fluorescence 
images are captured with a fluorescence microscope (Olympus, Inc.). 
SEM Imaging 
The following steps are taken to obtain SEM images of the cells’ growth on the glass and 
AAO surfaces. First, after 3 days of growth, the samples are rinsed with PBS. Then the neuron 
cells are fixed in 4% paraformaldehyde resolved in a 0.1 M phosphate (PO4) buffer with a pH of 
7.4 for 20 min at room temperature. Second, the samples are rinsed five times with PBS at room 
temperature, and then with a DI water rinse for 10 min. Third, dehydration is achieved by 
immersing the samples into solutions of 25%, 50%, 70%, 80%, 85%, 90%, 95%, and 100% 
ethanol for 10 min each, followed by an additional two rinses with 100% ethanol. Last, the 
samples are rinsed with three mixtures of ethanol and HMDS, with volume ratios of 3:1, 1:1, and 
1:3, for 10 min each. Then the samples are rinsed twice with pure HMDS for 10 min and left in 
the HMDS until completely dry. The samples are then ready for SEM imaging. 
Experimental Setup for Applying MS to N27 Neural Cells 
The Magstim 2002 monophasic stimulator with an ‘8’-shaped coil (Magstim D702 double 
70 mm) is used to apply MS to the cells, as shown in Figure S2a (Appendix. Supporting 
Information). The magnetic fields are generated in opposite directions through the two windings 
and are perpendicular to the surface of the ‘8’-shaped coil. As shown in Figure S2b, an upward 
magnetic field (MF) is generated from the left side of coil, and a downward MF is introduced 
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from the right. The power level is set to 100%, and the MF strength for the coil is shown in 
Figure S2c. The upward peak MF strength is ∼1.5 MA/m, and the downward peak MF is ∼1.25 
MA/m. 
Statistical Analysis 
The study focuses on cell growth under two different experimental conditions. First, the 
cell morphology (i.e., area) of each single N27 cell on different substrates after a 48 h incubation 
period has been measured. Second, hundreds of single N27 cells have been captured inside each 
SU8 microholder, and the division process of each cell has been monitored by counting cell 
numbers in each SU8 microholder after a 48 h incubation period. For each case, several trials 
have been conducted to collect sufficient data for statistical analysis. The experimental 
conditions and parameters are summarized in Table 1. 











(cell size/area measurement) 
AAO substrate 1 24 h 3   370 
AAO substrate 2 24 h 3   429 
Glass substrate 24 h 3   196 
Cell division (cell count) Glass microchip 24 h 5   880 
AAO microchip 24 h 5   2073 
 
Specifically, for the morphometric analysis of N27 cells, experiments with N27 cells on 
three substrates (AAO-substrate1, AAO-substrate2, and glass substrate) have been carried out. 
For all experiments, MS is applied when the cells have been seeded and grow on the substrates 
24 h later. In other words, the cells settle on the substrate’s surface and are allowed 1 day of 
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growth before the application of MS. Three independent trials (NT = number of trials) have been 
performed for each substrate. For each trial, at least 65 cells (NC = number of cells) are selected 
for cell area measurement. More details can be found in Table S1 (Appendix. Supporting 
Information). To analyze the N27 cell division process, experiments on two types of microchip 
(AAO and glass) are performed. On both microchips, only microholders with single N27 cell 
captured in each are monitored in order to track cell division accurately. For both AAO and glass 
microchips, MS is only applied after one day (24 h) growth of the captured cells. Five 
independent trials are performed for each substrate. For each trial, at least 150 single N27 cells 
are captured in 150 microholders. More details can be found in Table S2 (Appendix. Supporting 
Information). SPSS statistical analysis is used to analyze the experimental data. Tests of 
normality, outliers, and homogeneity variance are performed for each group of data before a one-
way analysis of variance (ANOVA).34 The statistical significance is reported with p < 0.05 and p 
< 0.005 for each group of data. The one-way ANOVA test results are shown in the following 
section, and more detailed information about the statistical analysis can be found in Appendix 
(Supporting Information). 
 
Figure 2. N27 neural cell growth on nanoporous AAO-substrate2 (a-e) vs glass coverslip substrate (f-j): (a 
and f) after one day growth; (b and g) after three days growth (cells are indicated with red arrows); (c and 
h) AFM images of AAO surface and glass surface, respectively; (d, e and i, j) SEM images for a single 
N27 neural cell growing on AAO surface and glass surface, respectively. 
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Figure 3. F-actin and paxillin staining of N27 neural cells on nanoporous AAO-substrate2 and glass. (a) 
Cells stained for F-actin and paxillin after 24 h and 48 h on AAO-substrate2 and glass. The scale bar is 40 
μm. Whole cell F-actin as well as nuclear paxillin and cytosolic paxillin staining after (b) 24 h and (c) 48 
h. (d) Number of center to peripheral focal adhesions as identified by paxillin staining. (e) Number of 
binucleated cells. Error bars are 95% confidence intervals and nonoverlapping confidence intervals were 
considered statistically significant and marked with bars. 
Results and Discussion 
Spreading of N27 Cells on Different Substrates 
The N27 cells are seeded on an AAO nanoporous surface (Figure 2a,b) and on a coverslip 
glass surface (Figure 2f,g). Cells are then cultured in an RPMI medium supplemented with 10% 
fetal bovine serum, 1% L-glutamine, penicillin (100 U/mL), and streptomycin (100 U/mL). Petri 
dishes are used as the container, and all the samples are kept in an incubator (NUAIRE-5700) at 
37 °C in a humidified atmosphere of 5% CO2 during the cell culture process. It should be noted 
that both the coverslip glass surface and the AAO nanopore surface shown in Figure 2 are bare 
surfaces used directly after the cleaning process without any further surface treatment. As shown 
in Figure 2a,b, cells spread out clearly on the AAO nanoporous surface over the course of 24 h of 
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growth and 3 days of growth alike. As shown in Figure S3, cells can also spread out clearly on 
the common cell culture flask, similar to those on the AAO nanoporous surface. By contrast, 
“ball-shaped” cells are observed after 1 day of growth on coverslip glass (Figure 2f). After 3 
days of growth, over 50% of these cells still grow in clusters (Figure 2g), indicating that they 
have a relatively slower migration than those on the AAO nanoporous substrate.35−37 AFM 
images of the AAO substrate and glass substrate are shown in Figure 2c and Figure 2h, 
respectively. As indicated, the surface roughness of the AAO substrate is significantly greater 
than that of the coverslip glass. Clearly, the nanoporous surface of the AAO substrate is much 
preferred for cell adhesion and spreading.38−40 Thus, the morphology has obviously been 
improved compared to that of the cells on coverslip glass.41 The corresponding SEM images of a 
single N27 neural cell on the AAO surface and on the glass surface are shown in Figure 2d,e and 
Figure 2i,j, respectively. The nanopore structures on the AAO surface can facilitate the 
attachment, adhesion, and spread for N27 cells compared to the smooth surface of coverslip 
glass.38−40 It has also been reported that the cell adhesion does play an important role in cell 
proliferation of cancer cells based on biochemical analysis.42 To characterize the difference in 
adhesion shown on AAO and glass substrates, we fixed and stained for both F-actin and paxillin 
in N27 cells (Figure 3a). As suggested in Figure 2, cells on AAO substrates were frequently 
separated from each other as compared to glass. On glass, cells clustered together. This is 
frequently seen when cell migration is slow compared to cell proliferation.43 In addition, cells on 
AAO surface appeared to be better spread (Figure 3a). The formation of F-actin as well as focal 
adhesions occurs during adhesion, so we measured the levels of F-actin and paxillin, a protein 
that is localized to focal adhesions44,45 (Figure 3a). At 24 h after plating, there was a small 
enhancement in F-actin content in N27 cells plated on glass substrate vs AAO substrate (Figure 
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3b). This difference was eliminated at 48 h (Figure 3c). Interestingly, there appeared to be a 
significant paxillin signal coming from the nucleus in addition to that seen in focal adhesions 
(Figure 3a). Paxillin is known to shuttle into the nucleus to affect gene transcription that leads to 
proliferation.46,47 Enhanced shuttling to the nucleus appears to be due to turnover of paxillin in 
focal adhesions.48 The nuclear paxillin signal was the same at 24 h after plating on AAO or glass 
substrates (Figure 3b). However, at 48 h, the paxillin in the nucleus was significantly higher in 
cells plated on AAO substrates than cells plated on glass (Figure 3c). The opposite trend was 
seen for cytosolic paxillin, which was higher at both 24 h and 48 h on glass as it was on AAO 
substrates. This suggests more mature adhesions related to less motile cells. In addition to the 
enhanced paxillin localization in the nucleus, cells plated on AAO substrates had a lower number 
of central focal adhesions as compared to peripheral focal adhesions (Figure 3d). Furthermore, 
central focal adhesion numbers increased with respect to peripheral focal adhesion numbers as 
the plating time increased (Figure 3d). Central focal adhesions are a marker for less motile cells 
and tend to turnover slower.39,40 The absence of these central focal adhesions potentially explains 
the higher paxillin localization in the nucleus of the cell on AAO substrates. Indeed, others have 
shown similar focal adhesion characteristics on AAO substrates compared to 
 glass.39,40 Finally, when cells are highly adherent and lack motility, they tend to produce 
cytokinesis defects on 2D substrates, resulting in binucleated cells (Figure 3e). Taken together, 
an AAO substrate appears to better promote migration than a glass substrate, resulting in non-
clustered cells. The enhanced migration on AAO substrates is caused by the ability of focal 
adhesions to turnover quicker, leading to more paxillin in the nucleus. On glass substrates, 
migration is blocked, and central and stable focal adhesions are formed, which act to inhibit the 
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accumulation of paxillin in the nucleus as well as block proper cytokinesis of cells, resulting in 
more binucleated cells. 
Viability of N27 Cells on Different Substrates under MS 
To assess the viability of N27 cells under MS, cellular viability tests by calcein AM and 
propidium iodide (PI)-based live/dead assay have been performed.49 In these experiments, four 
substrates have been used, including coverslip glass, AAO substrate, glass microchip, and AAO 
microchip. All the surfaces of these substrates are coated with poly-D-lysine. MS is applied after 
the cells grow on these substrates for 24 h (i.e., one cell cycle). As expected,50 the cell 
morphology on the poly-D-lysine coated coverslip glass in Figure 4a,c is superior to that on bare 
coverslip glass in Figure 2f,g and closer to that on bare AAO substrate in Figure 2a,b and poly-
D-lysine-coated AAO substrate in Figure 4b,d. As evident from the fluorescence images (Figure 
4a-d) and viability quantification of the cells (Figure 4e) on the four substrates, MS has a 
negligible cytotoxic effect on cells. Furthermore, as shown in Figure 4c,d, cell division can also 
be observed clearly. For example, in the image from the glass microchip in Figure 4c, a single 
N27 cell is captured and divided into two daughter cells 24 h (one cycle) later. At this point, MS 
is applied, and the two daughter cells grow and are divided into five live cells 24 h later (another 
cell cycle). Similarly, on the AAO microchip seen in Figure 4d, a single N27 cell is divided into 
two daughter cells 24 h later without MS. At this point, MS is applied, and the two daughter cells 
grow and are divided into six daughter cells after another 24 h. 
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Figure 4. Effect of MS on N27 cell viability. Live/dead assay on N27 cells cultured on (a) coverslip glass, 
inset is the close up image of N27 cells, (b) AAO-substrate2, inset is the close up image of N27 cells, (c) 
glass microchip (cells are indicated with red arrows), (d) AAO-substrate2 microchip (cells are indicated 
with red arrows). Green (calcein AM) and red (propidium iodide: PI) denote live cell and dead cell, 
respectively. MS is applied at 24 h: (e) % viability of N27 cells cultured on four substrates for 24 h (blue) 
and 48 h (orange), respectively. NS denotes no statistically significant difference. 
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MS Effects on N27 Neural Cell Growth 
MS effects on morphology (area) of N27 cells on glass and AAO substrates 
In these experiments, both AAO substrates were statistically different from the glass 
substrate. However, there is no significant statistical difference in the N27 cell morphology on 
AAO-substrate1 in comparison to that on the AAO-substrate2, suggesting that differences in 
nanopore size and porosity among AAO substrates have no clear effect on cell growth. The cell 
areas on the three substrates (AAOsubstrate1, AAO-substrate2, and glass) with and without MS 
are shown in Figure 5b (2−4).  
 
Figure 5. (a) Representative images showing N27 cells grown on a nanoporous AAO-substrate1; their 
sizes (areas) are measured by an imaging analysis software. (b) Quantification of cell size of N27 cells 
cultured on three different substrates without or with MS at 24 h. Asterisks * and ** denote statistically 
significant differences with p < 0.05 and p < 0.005, respectively. NS denotes no statistically significant 
difference.  
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The area of the cell without MS on AAO-substrate1 (∼538 μm2) is larger than that (∼520 
μm2) with MS. Similarly, on AAO-substrate2, the cell area without MS (∼551 μm2) is larger 
than that with MS (∼537 μm2). In terms of the glass substrates, the cell area without MS (∼582 
μm2) is also larger than that with MS (∼519 μm2). Detailed statistical analysis can be found in 
Appendix (Supporting Information). All the results indicate that MS indeed affects cell 
spreading. Specifically, for all three substrates, the area of the cells that received MS is 
statistically smaller than that of the ones that did not receive MS. It is important to note that MS 
is applied to the cells after 24 h of growth, or one cell cycle, and that the measurements are taken 
24 h later. 
MS effects on the cytoskeleton and paxillin localization 
In addition to spreading area, we analyzed the F-actin content as well as paxillin 
localization in cells with and without MS. While the substrate type (glass vs AAO substrates) did 
affect cell morphology, there were no gross changes in the cell morphology after MS (Figure 3a 
and Figure 6a). In addition, there were no large differences in the cytosolic paxillin fluorescence 
compared to that with and without MS (Figure 6b). Interestingly, the paxillin level in the 
nucleus, which was high on AAO substrates, decreases when the cells were treated with MS and 
could be associated with changes in transcription brought on by MS (Figure 6b). This was not 
seen on glass and may only be observable in well-spread cells. MS did not seem to change the 
central to peripheral focal adhesion ratio on AAO substrates, but it did decrease it on glass 
(Figure 6c). Finally, there is a small increase in the number of binucleated cells after MS on 
AAO substrates (Figure 6d). Taken together, it appears that MS decreases paxillin localization to 
the nucleus. This likely leads to or is caused by enhanced adhesion, resulting in cytokinesis 
defects leading to binucleated cells. 
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Figure 6. F-actin and paxillin staining of N27 neural cells on nanoporous AAO-substrate2 after magnetic 
stimulation (+MS). (a) Cells stained for F-actin and paxillin after 48 h on AAO substrate2 and glass and 
with or without MS at 24 h. The scale bar is 40 μm. (b) Whole cell F-actin as well as nuclear paxillin and 
cytosolic paxillin staining after 48 h on AAO or glass substrates with and without MS. (c) Number of 
center to peripheral focal adhesions as identified by paxillin staining. (d) Number of binucleated cells. 
Error bars are 95% confidence intervals and nonoverlapping confidence intervals were considered 
statistically significant and marked with bars.  
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MS effects on single N27 neural cell on microchips 
To assess the effect of MS on cells more efficiently, arrayed microholder chips have been 
used to monitor the division process of single cells subject to MS. First, cell synchronization is 
needed to ensure that the cells are at the same stage of the cell cycle, which can be achieved 
using the serum deprivation method described in Materials and Methods.32,33 Second, to monitor 
the cell division process accurately, one single N27 cell is captured in each microholder, 
enabling its division process to be tracked over the following days. To this end, several steps are 
required to maximize the capture of the single cell into each microholder: (1) After cells are 
detached from the bottom of the cell culture flask, they are pipetted into a sterile culture tube 
(Corning) that is put on a vortex mixer (VX200-Labnet) with a rotation speed of 500 rpm. This 
step ensures that the cells are uniformly distributed in the tube and that there are no aggregated 
cells. (2) The concentration of cells is controlled close to 0.1 million/mL. On the basis of our 
experiments, 0.1 million/mL is the optimum cell concentration to maximize the number of 
microholders on-chip to capture a single cell when the cell solution is delivered to the chip by 
pipet. (3) The chip is given several gentle rinses with the culture medium (10% fetal bovine 
serum) to achieve optimum single cell capture. Accordingly, single cell division in a microholder 
is monitored by taking optical images at 0 h, 24 h, and 48 h, as shown in Figure 7. Figure 7a 
shows that, when MS is not administered, a cell typically divides into two daughter cells after 
one cell cycle (∼24 h) and into four cells after another cell cycle (∼48 h in total). However, 
when MS is applied at the 24 h mark, the two cells divide into more than six cells after another 
cell cycle (∼48 h in total), as shown in Figure 7b. As a result of MS, more than two new 
daughter cells manifest within the same period of time compared to the chip with cells that do 
not receive MS (Figure 7a). Clearly, the microholder chip provides a straightforward technical 
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platform to conduct an accurate analysis of the effect of MS on cell division. Several trials have 
been performed to study the MS effect. For each trial, three microchips with captured cells are 
immersed in cell media in three Petri dishes and are stored in an incubator (NUAIRE-5700) at all 
times save for when the MS is applied. Upward MS and downward MS are applied on two 
microchips, respectively, the third microchip serving as a control without any MS. The 
experimental details and analysis are summarized in Table S2 (Appendix. Supporting 
Information). First, statistical comparisons of cell division are conducted on the glass microchip 
and the AAO microchip without applying MS. Because no MS is applied to these cells, any 
differences in outcome are due solely to the surface properties of the glass and AAO surfaces. As 
shown in Figure 7c (1), the average number of cells (∼4.08) on the glass microchip is smaller 
than that (∼4.28) on the AAO microchip, a statistically significant difference. Detailed statistical 
analysis can be found in Appendix (Supporting Information). In short, the nanoporous surface of 
the AAO microchip affects N27 cell growth, promoting the cell division process in comparison 
with the flat surface of the glass microchip. 
Second, when upward-MS is applied to cells on a glass microchip after 24 h of growth, as 
shown in Figure 7c(2), the average cell number after a further 24 h (∼4.87) is greater than the 
cell number of the control group that received no MS (∼3.87). Similarly, when downward-MS is 
administered to cells on a glass microchip, the average cell number at the 48 h mark (∼4.64) is 





Figure 7. Representative images showing (a) the division of a single neuron cell in a microholder without 
TMS, and (b) the division of a single cell with MS. The cells are indicated with red arrows. (c) 
Quantification of cell number at 48 h in a glass microchip and AAO-substrate2 microchip without or with 
TMS at 24 h. Asterisks * and ** denote statistically significant differences, with p < 0.05 and p < 0.005, 
respectively. NS denotes no statistically significant difference. 
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Clearly, the average cell number without applying MS is statistically smaller than that 
with MS. This result indicates that MS can promote cell division. However, no statistical 
difference has been found between upward MS and downward MS, suggesting that the direction 
of MS has no effect on the cell division process in these contexts. Third, when MS is applied to 
cells on an AAO microchip after a 24 h period of growth, as shown in Figure 7c(3), the average 
cell number at the 48 h mark is ∼4.73 with upward MS and ∼4.85 with downward MS. By 
contrast, the average cell number of the control group receiving no MS is ∼4.18. These 
constitute similar results to those observed on the glass microchip. In both cases, the average 
number of cells is increased when MS is administered after 24 h (i.e., one cell cycle) of growth, 
indicating that the proliferation of N27 cells can be expedited by MS. The MS direction has no 
effect on cell division. Several important elements in the experiments should be noted. First, if 
the MS is applied immediately after the cells are seeded on the substrates or microchips, the 
experimental results are not consistent, and the viability of the cells is unpredictable. Allowing 
the cells to attach to the substrate and allowing them to grow for 1 day before applying MS are 
crucial steps to ensure consistent experimental results. Hence, we only focus on the experiments 
in which MS is applied to cells after cells have been given one full cycle of growth (24 h) on the 
substrate. Second, the effect of MS on cells can be clearly and immediately observed in one cell 
cycle (i.e., 24 h); hence we mainly focus on monitoring cells’ behaviors during a 24 h period 
after administration of MS. Notably, experiments that have monitored cell growth 72 h and 




This study constitutes the first investigation into the effect of MS on the viability, 
spreading, and proliferation of N27 cells at the single-cell level on different substrates. N27 cells 
have been found to have clear preference for growing on the bare nanostructured AAO surface as 
opposed to the bare coverslip glass surface. The nanostructures on the AAO surface allow the 
N27 cells to attach, spread, and migrate easily. The AAO surface appears to facilitate paxillin 
movement into the nucleus as well as limit central adhesions that inhibit or are the result of poor 
migration. A poly-D-lysine coating on either of these surfaces leads to no discernible difference 
in the spreading of the cells. A live/dead assay has shown negligible cytotoxic effects of MS on 
cell viability. Additionally, the study has evaluated the effect of MS on the adhesion and 
proliferation of single N27 cells by measuring cell sizes and monitoring the cell division process 
in the microholders on a chip. MS has been found to have a statistically significant effect on both 
cell morphology and cell division/proliferation, and it results in lower paxillin levels in the 
nucleus. Specifically, MS can expedite the division of N27 cells regardless of the direction in 
which it is applied. As a result, more N27 cells can be generated with MS than without. These 
results indicate that MS may help the proliferation and regeneration of neural cells; more largely, 
the results enhance current understanding of the potential for MS to be used in the treatment of 
neurological disorders. 
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Appendix. Supporting Information 
(1) Fabrication Process for SU8 Microholder 
The fabrication process flow for SU8 microholder chip with AAO nanoporous surface 
(AAO microchip) is described in Fig. S1. For SU8 microholder chip with glass surface (glass 
microchip), the fabrication process flow is similar to that in Fig. S1(a) but requiring only from 
step 4 to step 5 to fabricate SU8 microholders on glass substrate. 
 
Fig. S1: Arrayed SU8 microholder chip for studying the single N27 cell behaviors. (a) Fabrication process 
flow for AAO microholder chip. (b) A photo of microholders on chip and the close-up optical 
micrographs of arrayed SU8 microholders and the captured single neural cell N27. 
(2) Experimental Setup for Applying MS 
The Magstim 2002 monophasic stimulator with ‘8’ shape coil (Magstim D702 double 70 
mm) is used to apply MS on cells as shown in Fig. S2a. The directions of generated magnetic 
fields are opposite in the two windings and perpendicular to the surface of the ‘8’ shape coil. As 
shown is Fig. S2b, upward magnetic field (MF) is generated from left side of coil and downward 
MF is introduced from right side coil. The power level is set to 100% which is the maximum 
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power level of the stimulator, and measured MF strength for the ‘8’ shape coil is shown in Fig. 
S2c. The upward peak MF strength is ~1.5 MA/m and the downward peak MF is ~1.25 MA/m 
for the ‘8’ shape coil, respectively. 
 
Fig. S2: (a) Experimental setup for applying MS on cells inside microholder chips, the chips are kept in 
petri dish holders filled with cell media; the magnetic field direction is perpendicular to the chip surface, 
one is upward, the other is downward. No magnetic field is applied on the chip for the control experiment; 
(b) Sketch of the cross-section of the experimental setup; (c) The measured magnetic field strength and 
distribution generated by the MS generator (‘8’ shape coil). 
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Fig. S3: N27 cells cultured on three substrates after one-day growth and three-day growth (a-b) on bare 
AAO-substrate2; (c-d) on cell culture flask; (e-f) on bare coverslip glass. 
(3) Morphometric Analysis 
The morphometric analysis of N27 cells and experiments of N27 cells on three substrates 
(AAO substrate1, AAO substrate2, and glass) are summarized in Table S1. 
Table S1. Statistical results of MS effect on cell morphology on different substrates. 
Substrate & MS treatment 
Cell 
numbers 







AAO-substrate1 (no MS) 199 538.67 56.25 3.99 
0.002 
AAO-substrate1 (with MS) 171 520.52 55.48 4.24 
AAO-substrate2 (no MS) 252 551.36 68.94 4.34 
0.032 
AAO-substrate2 (with MS) 177 537.04 68.41 4.99 
Coverslip glass (no MS) 100 582.12 90.92 9.09 
0.0 
Coverslip glass (with MS) 96 519.15 97.26 9.93 
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(4) Cell Division Process 
 Cell division process analysis of N27 cells and experiments on two microchips (glass 
microchip and AAO microchip) are summarized in Table S2. 
Table S2. Statistical results of MS effect on cell division on microchip 
Microchip and MS treatment 
No. of 
cells 
Mean cell number in each 
microholder after 48 h (one 








a) Glass microchip w/o MS 348 3.87 1.79 0.10 
(a, b) = 0.002 
(a, c) = 0.000 
(b, c) = 0.432 
b) Glass microchip w/ 
upward-MS at 24 h 
285 4.87 2.17 0.13 
c) Glass microchip w/ 
downward-MS at 24 h 
247 4.64 2.18 0.14 
e) AAO microchip w/o MS 625 4.18 2.03 0.08 
(e, f) = 0.000 
(e, g) = 0.000 
(f, g) = 0.514 
f) AAO microchip w/ 
upward-MS at 24 h 
728 4.73 1.99 0.07 
g) AAO microchip w/ 
downward-MS at 24 h 
720 4.85 2.26 0.08 
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Abstract 
This paper reports the behaviors of neuron cell N27 growth on nanostructured surfaces, 
and under transcranial magnetic stimulation (TMS) at single cell level for the first time. The 
growth of neuron cell N27 on anodic aluminum oxide (AAO) nanoporous surfaces has been 
studied. It has been found that cells show preference to grow on the nanostructured surface 
compared with the flat coverslip glass surface. The sizes of cells grown on AAO nanoporous 
surfaces with and without TMS were studied. It was found that the sizes of cells with TMS 
treatment are statistically smaller than those without TMS treatment in the same period of time, 
indicating the TMS might speed up the cell division. To verify this observation, the growth of 
single N27 cells inside SU8 microholders with and without TMS has been investigated. It has 
been found that up to 17% more daughter cells can be produced when the cells are subjected to 
TMS compared to those without TMS. All these results suggest the TMS can contribute to the 
growth of N27 cells. 
Introduction 
Nanostructured bio-interfaces are one of the fastest emerging fields in biomedical 
engineering. For instance, over the past years, the unique properties of nanoporous anodic 
alumina oxide (AAO) thin film have greatly contributed to the development of a variety of novel 
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biomedical and medicine applications, ranging from biofiltration membranes, lipid bilayer 
support structures, biosensing devices, and implant coatings to drug delivery systems with AAO 
capsules and scaffolds for tissue engineering [1-6]. Additionally, nanoporous AAO membranes 
have attracted increasing interest as cell-interface substrates for manifold cell types [7]. On the 
other hand, transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation 
technique that uses time varying short pulses of magnetic field to induce an electric field in the 
tissues of the brain, thus modulating the synaptic transmission of neurons. This neuromodulation 
technique can be used to excite or inhibit the firing rate of neurons as a treatment for various 
neurological disorders such as major depressive disorder, Parkinson's disease, post-traumatic 
stress disorder and, migraine [8-9]. The molecular/cellular mechanisms of neurons under TMS 
are complex. Hence, the effects of TMS on individual neurons needs to be thoroughly 
understood in order to fully utilize the benefits of TMS as a neuromodulation tool for treating 
neurological disorders. 
Herein, we report on the studies of neuron cell growth on the AAO nanoporous surface 
and also the effect of TMS on single neuron cells using a microchip. 
Materials and Methods 
Neuron Cell N27 
Immortalized rat mesencephalic cells (1RB3AN27, N27 for short) are used in the 
experiments, these cells are grown in RPMI medium supplemented with 10% fetal bovine serum, 
1% L-glutamine, penicillin (100 U/ml), and streptomycin (100 U/ml), maintained at 37 °C in a 
humidified atmosphere of 5% CO2. 
Preparation of AAO Nanoporous Substrate and Glass Substrate 
Preparation of AAO nanoporous substrate is briefly summarized as follows. After a layer 
of Al is deposited on a glass substrate, a one-step anodization process is carried out to convert Al 
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into nanoporous AAO thin film [10]. A SEM image of the AAO thin film is shown in Fig. 1. 
Both AAO nanoporous substrates and glass substrates, were cleaned with DI water by 
ultrasonicator (BARNSON 1510 - Fisher Scientific) for 5 mins, then disinfection of these 
substrates is achieved by cleaning with Acetone and Methanol by ultra sonicator for 5 mins in 
sequence. Then they were cleaned with DI water by ultra sonicator for 5 mins and dried by a 
nitrogen gun, followed by air plasma cleaning (Harrick plasma-Pcd 32G) for 3 mins. Finally, 
they were baked on a hot plate at 150°C for 5 mins before they are ready for use. In some 
experiments, poly-D-lysine is coated on the substrates before the cells are seeded for 
experiments. 
 
Figure 1: SEM image of the AAO nanoporous surface fabricated using one-step anodization process.  
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Microholder Chip Fabrication 
Microholders on a glass substrate are fabricated from polymer SU8 using a standard 
optical lithography process. The size of the microholders was designed as 180 μm × 180 μm so 
that the N27 cells can fully grow without any spatial limitations. A photo of the fabricated SU8 
microholder chip and a close-up optical micrograph of four microholders are shown in Fig. 2. 
 
Figure 2: Photo of the arrayed SU8 microholders and their close-up for studying the behaviors of single 
neuron cell. 
Experimental Setup for Applying TMS on Neurons 
A figure-of-eight coil was used to apply TMS to cells as shown in Fig. 3(a-b). On the left 
side of the coil, the direction of the magnetic field (MF) is upward and perpendicular to the chip 
holder, while the direction of the MF on the right side of the coil is downward. Three chips in 
three holders were used for the experiments. The magnetic field (H) was measured using a 
Gaussmeter and an axial Hall probe. The measured MF strength of the figure-of-eight coil is 
shown in Fig. 3(b). The upward peak MF strength is ~1.5 MA/m and the downward peak MF is 
~1.25 MA/m for the figure 8 coil, respectively. 
52 
 
Figure 3: (a) Experimental setup for applying TMS to cells inside microholder chips, the chips are kept in 
petri dish holders filled with cell media; the magnetic field direction is perpendicular to the chip surface, 
one is upward, the other is downward. No magnetic field is applied on the chip for the control experiment; 
(b) sketch of the cross-section of the experimental setup; (c) the measured magnetic field strength and 
distribution generated by the TMS generator using the figure-of-eight coil. 
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Results and Discussion 
Neuron Cells Growth on Nanoporous Surface vs. Glass Surface 
The following phenomena have been observed: for the AAO and glass substrates, (1) if 
both substrates are not coated with poly-D-lysine, after the cells are seeded on them, the growth 
(adhesion and spreading) of N27 cells on the AAO surface are much better than that on the glass 
substrate; (2) if both substrates are coated with poly-D-lysine, the growth of N27 cells on poly-
D-lysine coated glass substrate becomes better, but not as good as that on poly-D-lysine coated 
AAO substrate. Representative optical images of the N27 cells on AAO, and glass substrates 
after one day growth are shown in Fig. 4(a) and Fig. 4(d), respectively, and after three days are 
shown in Fig. 4(b) and Fig. 4(e), respectively. The AFM images of the AAO substrate and glass 
substrate are shown in Fig. 4(c) and Fig. 4(f), respectively. As shown, the roughness of the 
surface of AAO substrate is much larger than that of the coverslip. Clearly, the nanoporous 
surface of the AAO substrate is much preferred, in comparison with the surface of the glass 
coverslip, for cells’ adhesion and spreading [11]. 
Another observation is that, if the glass substrate is subjected to an air plasma treatment, 
then coated with ploy-D-lysine several times, the growth of N27 cells becomes essentially 
similar to that on AAO nanoporous substrate. It should be noted that even without any plasma 
treatment and poly-D-lysine coating, the growth of N27 on AAO nanoporous substrates is 




Figure 4: Optical images showing the N27 cell growth on nanoporous substrate (a-b) vs. glass coverslip 
substrate (d-e): (a) and (d) after one day growth; (b) and (e) after three day growth (cells are pointed by 
red arrows); AFM images of (c) AAO nanoporous surfaces and (f) glass surface. 
Effect of TMS on the Behavior of Neuron Cells 
Several trials have been conducted to study the TMS effect on the behavior of N27 cells 
by monitoring the size (area) of the cells. In these experiments, cells seeded on poly-D-lysine 
coated AAO surface have been investigated. The direction of the applied TMS on cells is 
illustrated in Fig. 3. 
Representative images showing the sizes (areas) of N27 cells, which are measured by an 




Figure 5: (a) Representative images showing N27 cells grown on a nanoporous AAO substrate; their sizes 
(areas) are measured by an imaging analysis software; N27 cells on poly-D-Lysine coated AAO 
nanoporous substrate (b) with a thickness of 1.3 μm and (c) with a thickness of 2.5 μm with TMS vs 
without TMS. 
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In Fig. 5(b-c), the measured sizes (areas) of the cells with and without TMS are given. It 
is clearly shown that the average size of the cells with TMS is about 4.5% smaller than that of 
cells without TMS during the same period of time. The measured sizes (areas) of cells with TMS 
are statistically smaller than those without TMS, suggesting that the division of cells with TMS 
might occur earlier than that of cells without TMS, namely the TMS might speed up the division 
of the cells. 
Single Neuron Cell Growth in Microholders 
In order to examine if the TMS can speed up the division of N27 cells, single N27 cell 
growth behavior in a microholder without and with TMS has been studied. 
Cell synchronization 
In order to monitor the cell division accurately, cell synchronization, a process by which 
cells at different stages of the cell cycle in a culture are brought to the same phase, has been 
implemented in our experiments. The method we used is serum deprivation. Serum deprivation 
is a simple and reliable method by changing the percentage of fetal bovine serum from 10% to 
1% in the medium. 9 hours before seeding the cells to the microholders, we replaced the medium 
with 10% fetal bovine serum with that with 1% fetal bovine serum to the cells. Because the 
bovine serum is essential for the growth of N27 cells, the risk of cell death increases with the 
serum deprivation time. We chose 9 hours to make sure the cells will not die because of the 
serum deprivation. 
Cells seeding 
Before we seeded cells from the flask to microholder devices, trypsin was used to detach 
the cells from the bottom of flask. After 2 or 3 minutes, we pipetted normal medium with 10% 
fetal bovine serum to the flask. Then the cells were ready to be seeded into microholder devices. 
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Representative optical images showing the single cell growth in microholders without 
TMS and with TMS are shown in Fig. 6(a) and Fig. 6(b), respectively. As shown in Fig. 6(a), 
without TMS, as expected, in most cases, one cell divides into two cells after one cell cycle (~24 
hours), then the two cells divide into four cells after another cell cycle (~48 hours). In contrast, in 
Fig. 6(b), one cell divides into two cells after one cell cycle (~24 hours), immediately at this 
point, the TMS is applied. After another cell cycle (~48 hours), the two cells divide into more 
than six cells. As a result, due to TMS, more daughter cells have been produced. 
In order to analyze the effect of TMS more accurately on the cell division, the following 
experiments and analysis schemes have been carried out. Under ideal growth conditions, one 
parent cell divides into two daughter cells in the first cell cycle (~24 hours), then into four 
daughter cells in the second cell cycle (~48 hours) [12]. The difference between the number of 
cells with/without TMS and the number of cells under ideal growth condition can be calculated 
using the formulas: 
Δdifference = Nw / TMS - Nideal  and Δdifference = Nw/o TMS - Nideal 
where 
Nideal = number of cells under ideal culturing conditions 
Nw / TMS = number of cells for the group that received TMS 
Nw/o TMS = number of cells for group that did not receive TMS 
The ratio R = Δdifference / Nideal is used to evaluate the TMS effect on cell division. First, 
the TMS is applied immediately after the cells are seeded into microholders. As shown in Fig. 
6(c), two trials have been carried out. In Trial 1, the ratio R is about +2.44% when an upward 
TMS is applied, the ratio is about +2.77% under a downward TMS. In the control experiment, 
the ratio is about -9.09% without applying TMS. In Trial 2, the ratio R is about +4.67% when an 
58 
upward TMS is applied, the ratio is about +5.49% under a downward TMS. In the control 
experiment, the ratio is about -6.22%. For both trials, the net ratio R = R - Rcontrol is 10.89% - 
11.53% under an upward TMS, and 11.71% - 11.86% under a downward TMS, respectively. 
 
        
Figure 6: Representative images showing (a) the division of a single neuron cell in a microholder without 
TMS, (b) the division of a single cell with TMS (cells are pointed by red arrows); the measured ratio 
(Δdifference / Nideal) under TMS vs. no TMS: (c) TMS applied immediately after cells seeded into 
microholders; (d) TMS applied after cells’ growth inside microholders for 24 h. 
 
In Fig. 6(d), the TMS is applied after 24-hour cell growth. In Trial 1, the ratio is about 
+18.72% when an upward TMS is applied, the ratio is about +18.62% under a downward TMS. 
In the control experiment, the ratio is about 2.67%. In Trial 2, the ratio is about +21.93% when 
59 
an upward TMS is applied, the ratio is about +19.75% under a downward TMS. In the control 
experiment, the ratio is about 5.11%. For both trials, the net ratio R=R-Rcontrol is 16.05-16.56% 
under an upward TMS, and 14.64-15.95% under a downward TMS, respectively. 
Note that in each trial, the growth of about 100 single cells has been monitored. Based on 
these experiments, the TMS effect on cell growth is obvious. When the TMS is applied after 
cells’24 h growth, the effect becomes even stronger. 
Summary 
In this paper, a nanoporous AAO surface has been evaluated for the growth of N27 cells. 
It has been found that N27 cells have clear preference to grow on the nanostructured surface 
rather than the flat surface. In addition, the effect of TMS on the growth of single N27 cells has 
been studied by measuring their size and monitoring their cell division in the microholders. It has 
been found that TMS can increase cell division, up to ~17% more daughter cells are divided in 
the same cell cycle compared to those without TMS. 
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Abstract 
Much of the biomedical research to find the causes of and treatments for Parkinson's 
Disease (PD) and Alzheimer's Disease (AD) is performed using cell lines from animals that 
model the behavior of cells in the human brain that are linked to PD and AD. The N27 
dopaminergic cell line is well-established in neurodegenerative disease research. [1] [2]. 
Transcranial Magnetic Stimulation (TMS) has been approved by the U.S. Food and Drug 
Administration (FDA) as a method for treating major depressive disorder (MDD), obsessive-
compulsive disorder (OCD) and certain types of migraine headaches [3]. However, the effect of 
TMS type fields at the cellular level are not fully understood. Recent studies have shown that 
monophasic pulsed magnetic fields generated by a TMS stimulator increases growth and 
proliferation of N27 cells in vitro [4] [5] [6]. 
In TMS therapy, each session is tailored to the specific patient by establishing a base 
threshold level of magnetic field strength (H). This is performed by aiming the stimulation coil at 
the patient’s motor cortex and finding the minimum intensity level to make the patients thumb 
visibly twitch. This H field intensity baseline, called the motor threshold (MT), is then multiplied 
by a specified percentage set by the therapy protocol established by the FDA. Different patients 
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have different MTs. Therefore, the intensity of the H field delivered to the brain cells of different 
patients should also vary. 
Recent studies have shown that monophasic pulsed magnetic fields generated by a TMS 
stimulator increases growth and proliferation of N27 cells in vitro [4] [5] [6]. The goal of our 
research is to investigate the effects of different H field intensities on N27 cells. By modulating 
the H field, an exploration was made into the role of variable H field intensity experienced 
during TMS therapy due to different MT between patients. The results of our research will 
increase our understanding of the effects of magnetic fields at the cellular level, increase the 
knowledge of the underlying mechanisms behind TMS, and contribute the ongoing research into 
treatments for PD and AD. 
Introduction 
Transcranial Magnetic Stimulation (TMS) is a neuromodulation technique which is 
capable of non-invasively activating neurons in the brain. TMS is approved by the U.S. Food and 
Drug Administration (FDA) for treating major depressive disorder, obsessive compulsive 
disorder, and certain types of migraine headaches. In TMS therapy, each session is tailored to the 
patient by initially establishing a baseline of magnetic field strength (H) called the Motor 
Threshold (MT). The MT is then multiplied by a specified percentage established by the FDA for 
each type of therapy. Different patients have different MTs. Therefore, the intensity of the H 
field delivered to the brain cells of different patients should also vary. The goal of our research is 
to investigate the effects of different H field intensities on N27 dopaminergic cells. We chose the 
N27 cell line because it is well established in biomedical research for neurodegenerative 
diseases. By modulating the H field, an exploration was made into the role of variable H field 




The chart in Fig. 1 shows the timeline followed during all of the experimental trials. 
 
Fig. 1. The major events of the experimental trials at their respective time points during each trial. 
2D Extracellular Matrices (ECMs) 
Collagen coated glass cover slips, and poly-D-lysine (PDL) coated glass cover slips were 
used as the structural growth media for experiments. 
Cell Culture 
Rat mesencephalic cells (N27) were cultured in RPMI 1640 [+ L-Glutamine] medium 
supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 U/ml), 
maintained at 37 °C in a humidified atmosphere of 5% CO2. 
Magnetic Stimulation 
A commercially available Magstim 2002 monophasic stimulator, along with two 
commercially available coils from the Magstim company, were used to apply to magnetic 
stimulation to the cells. The two coils used were the D702 figure-8 coil and the single 90 mm 
circular coil. The stimulator was set at 100% power output for the stimulation sessions. The cells 
received 150 pulses in single 12 min session. The pulse rise time was ~100 µs with a duration of 
1 ms. The frequency of the stimulation pulse was 1 kHz. 
Measured Magnetic Fields 
The magnetic field strength (H) for each coil was measured using a Gaussmeter and an 
axial Hall probe. The placement of the Hall probe was 20 mm from each coil, respectively. This 
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is the distance between the coils and the ECM coated cover slips during the experiments. The 
measured peak H field for the D702 figure-8 coil was 0.5593 T (0.4451 MA/m). The measured 
peak H field for the 90 mm circular coil was 0.4728 T (0.3762 MA/m). The peak H field of 
figure-8 coil is 18.31% greater than the peak H field of the single 90 mm coil. 
Stimulation Schematic 
The placement of the well plates that held the glass cover slips during the experiment 
trials with respect to each of the stimulation coils are shown in Fig. 2. 
 
Fig 2. Location of the glass coverslips used for growing the N27 cells with respect to the TMS coils 
during stimulation using the (a) D702 figure-8 coil and the (b) 90 mm circular coil. 
Results 
The numbers of cells counted at each time point during the trials are plotted in Fig. 3 for 
the 90 mm circular coil, and Fig 4. for the D702 figure-8 coil.  
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Fig. 3. Comparison of cell numbers with respect to time. Magnetic stimulation applied using the 90 mm 
circular coil at 24 hr time point after seeding cells on collagen and PDL ECMs, respectively. 
 
 
Fig. 4. Comparison of cell numbers with respect to time. Magnetic stimulation applied using the D702 
figure-8 coil at 24 hr time point after seeding cells on collagen and PDL ECMs, respectively. 
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Figure-8 Coil Statistical Analysis 
Fig. 5 shows the analysis of the cells (stimulated compared with non-stimulated) using 
the figure-8 coil for stimulation while being grown in the different ECMs.   
 
Fig. 5. The groups that received TMS, show an increase in proliferation rate compared to the groups that 
did not receive TMS. This increase occurred on both ECMs, collagen and poly-D-lysine.  
Discussion 
Monophasic TMS fields, at sufficient intensity, and given in a single session, increase the 
proliferation rate of N27 neuronal cells. This increase occurs on collagen and on poly-D-lysine 
ECMs. By modulating the H field, a threshold of the sufficient intensity is shown to exist 
between 0.4728 T and 0.5593 T. Further research into the effects of TMS on the internal cellular 
processes of N27 cells are currently in progress. 
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Abstract 
Transcranial Magnetic Stimulation (TMS) is an approved treatment for major depressive 
disorder (MDD) and obsessive compulsive disorder (OCD) by the U.S. Food and Drug 
Administration (FDA). The underlying mechanisms that make TMS effective are still being 
discovered as researchers continue to discover more applications for TMS.  
Much of the biomedical research to find the causes of and treatments for Parkinson's 
Disease (PD) and Alzheimer's Disease (AD) is performed using PC-12 neuronal cells (Rattus 
norvegicus, pheochromocytoma) that model the behavior of cells in the human brain that are 
linked to PD and AD. Many studies have reported the effects of magnetic stimulation on neurite 
growth of PC-12 neuronal cells. However, interpreting the effects of electromagnetic fields on 
neuronal cells and comparing results from multiple studies can be challenging due to the many 
variables involved in these types of experiments: monophasic vs bi-phasic time-dependent 
signal, type of magnetic field; AC vs DC, amplitude of the magnetic field, duration/frequency of 
time-varying magnetic pulses, number of total pulses and length of time under a steady state 
field. The aim of this study is to investigate the effects of time-dependent magnetic fields on 
neurite growth of PC-12 cells using the equivalent dose given during TMS treatments. 
During TMS treatment, neurites will experience the applied field according to their 
orientation within the brain. Our research probed the consequence of applying the equivalent 
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dose magnetic field experienced in TMS sessions in different orientations with respect to the 
growth surface plane of the neurites. Each stimulated cell group had a control group that was 
subjected to all the same experimental steps except TMS. 
Introduction 
Transcranial Magnetic Stimulation (TMS) is approved by the U.S. Food and Drug 
Administration (FDA) as a method for treating major depressive disorder (MDD), obsessive 
compulsive disorder (OCD), and certain types of migraine headaches. However, the effect of 
TMS type fields on the brain has yet to be fully investigated at the cellular level. Our research 
investigated the effects of monophasic pulsed magnetic fields generated by a commercial TMS 
stimulator and coil on the growth of neurite extensions of PC-12 cells stimulated with nerve 
growth factor beta (NGFβ). 
When TMS is applied to a patient, neurites will experience the applied field according to 
their orientation within the brain. Our research probed the consequence of applying the magnetic 
field in different orientations with respect to the growth surface plane of the neurites. 
Our previous work showed that a single session of stimulation applied orthogonal to the 
growth surface increased the average length of neurite extensions on PC-12 cells. Our current 
work is exploring the effects multiple stimulation sessions on PC-12 neurite growth when the 
field is applied orthogonal, and when it is applied parallel to the growth surface. The cells were 
given multiple short stimulation sessions that were repeated daily for several days. The protocol 
is the same that is used in TMS therapy and clinical research. Each stimulated cell group had a 






The chart in Fig. 1 shows the timeline followed during the experimental trials. 
 
Fig. 1. The major events of the experimental trials at their respective time points during each trial. 
Cell Preparation 
The PC-12 cells were cultured in 1640 RPMI [+ L Glutamine] medium supplemented 
with 10% horse serum, 5% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 
U/ml), maintained at 37 °C in a humidified atmosphere of 5% CO2. The extracellular matrix used 
was Matrigel (50 μg/ml diluted 1:8 with 1640 RPMI). Prior to seeding the cells, the Matrigel was 
applied to bottom of the wells, then incubated at room temperature for 60 min. The cells were 
seeded with 1640 RPMI [+ L Glutamine] medium supplemented with 1% horse serum, penicillin 
(100 U/ml), and streptomycin (100 U/ml), and 50 ng/ml NGFβ. 
Magnetic Stimulation 
A commercially available Magstim 2002 monophasic stimulator was used along with a 
commercially available D702 figure-8 coil from the Magstim company to apply magnetic 
stimulation to the cells. The stimulator was set at 95% power output for the stimulation sessions. 
The cells received 150 pulses in single 12 min session. The pulse rise time was ~100 µs with a 
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duration of 1 ms. The frequency of the stimulation pulse was 1 kHz. Stimulation sessions were 
repeated every 24 hours for a total of 4 stimulation sessions per trial.  
Field Strength of TMS Coil 
The magnetic field strength (H) generated by the coil was measured using a Gaussmeter 
and an axial Hall probe. The placement of the Hall probe was 12 mm from the. This is the 
distance between the coil and the cells in the wells during the experiments. The maximum field 
strengths were measured multiple times and averaged. The averaged measured peak H field for 
the D702 figure-8 coil was calculated to be 0.509 T (0.405 MA/m). 
Stimulation Schematic 
The placement of the well plates that held the cells during the experiments with respect to 
the stimulation coil is shown in Fig. 2. 
 
Fig 2. Location of the cells in the well plates with respect to the TMS coil during stimulation sessions. 
The white arrows indicate the direction of the applied magnetic field. 
Methods of Measurement 
Image J software was used to measure the angle of growth of the neurite extensions from 
the main cell body with respect to a fixed reference point. Two types of measurements were 
taken of each extension as shown by the examples in Fig. 3.  
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Fig. 3. Examples of how the neurite extensions were measured using Image J software. On the left is a 
measurement from the base of the extension to the tip of the longest branch. On the right is an example of 
measuring the angle of the primary branch of the extension as it grows from the main cell body.  
Results 
Measurement data of the neurite extensions were plotted as histograms in polar 
coordinates as shown in Fig. 4. This plotting method allows the analysis of the distribution of the 
neurite’s direction of growth with respect to the main cell body, and the direction of the applied 
magnetic field. 
 
Fig. 4. The histograms show the directional distribution of neurite growth with respect to the direction of 
the applied magnetic field as shown in the stimulation schematic in Fig. 2. 
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Statistical Analysis 
The method used to statistically analyze the measured angles of the extensions is called 
the Directionality Index (DI). The DI = -cos (θ), where θ is the angle of the primary branch or the 
angle of the base to tip measurement with respect to magnetic field direction. Fig. 5 shows box 
plots that represent the average DI for each experimental group. Statistical analysis shows that 
the there is no significant preference in the direction of new neurite extensions or overall 
direction of neurite extension growth with respect to the direction of the applied magnetic field 
for any group. 
 
Fig. 5. Box plots representing the average Directionality Index (DI) for each experimental group with 
error bars that represent the 95% confidence interval of the standard deviation for each group. 
Discussion 
The magnetic stimulation was applied in short sessions and repeated daily over several 
days. This method is the same that is used in TMS therapy and clinical research. The stimulation 
protocol did not result in a directional bias of new neurites or a directional bias of overall neurite 
growth after several days. These results show that PC-12 neurite extensions experienced no 
adverse effects on directionality of growth as a result of magnetic fields used in TMS therapy 
and clinical research. 
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Abstract 
Much of the biomedical research to find the causes of and treatments for Parkinson's 
Disease (PD) and Alzheimer's Disease (AD) is performed using cell lines from animals that 
model the behavior of cells in the human brain that are linked to PD and AD. Two of the animal 
cell lines used for PD and AD research are the PC-12 neuronal cells and the N27 dopaminergic 
neuronal cells. PC-12 cells are non-adherent cells that do not attach to surfaces during their 
growth cycle. N27 cells are adherent cells that attach and spread out on surfaces during their 
growth cycle. [1] [2] [3] [4]. We chose these two cell types for our research because of their 
well-established results in neurodegenerative disease research. 
Transcranial Magnetic Stimulation (TMS) has been approved as treatment for major 
depressive disorders by the U.S. Food and Drug Administration (FDA) since 2008 [5]. The 
major effect of time dependent magnetic fields on the brain has yet to be fully investigated at the 
cellular level. Our research used the stimulation protocol used in TMS therapy. A predetermined 
number of magnetic pulses were applied within a short time period using a Magstim 2002 
monophasic stimulator with the Magstim D702 figure eight dual 70 mm high-focality coil [6]. 
Using this protocol, we observed the effects of magnetic fields that are experienced by cells in 
TMS therapy in vivo. Our research showed that pulsed magnetic fields increased the 
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proliferation of N27 cells grown on collagen coated and Poly-D-Lysine coated glass cover slips 
as shown in Figure 1. Each stimulated cell group had a control group that was subjected to all the 
same experimental steps except TMS [7]. 
Our current work is exploring the effects of magnetic stimulation on the growth and 
proliferation of PC-12 cells free floating in growth media and while in a collagen-hyaluronan 2D 
extra cellular matrix. The results of our research will increase our understanding of the effects of 
magnetic fields at the cellular level, increase the knowledge of the underlying mechanisms 
behind TMS, and contribute the ongoing research into treatments for PD and AD. 
Introduction 
Much of the biomedical research investigating the causes of, and treatments for, 
Parkinson's Disease (PD) and Alzheimer's Disease (AD) is performed using animal cell lines that 
model the behavior of cells in the human brain. Two of the animal neuronal cell lines used for 
PD and AD research are the PC-12 and the N27.  PC-12 cells are non-adherent type cells that do 
not attach to surfaces during their growth cycle. N27 cells are adherent type cells that attach and 
spread out on surfaces during their growth cycle.  
Transcranial Magnetic Stimulation (TMS) is a U.S. Food and Drug Administration 
(FDA) approved method for treating major depressive disorder and obsessive-compulsive 
disorder. The effect of time-dependent magnetic fields used in TMS have yet to be fully 
investigated at the cellular level. Our previous research showed that pulsed magnetic fields 
generated by a TMS stimulator increased the proliferation of N27 cells grown on collagen coated 
and Poly-D-Lysine coated substrates. Our current work explored the effects of the same 
stimulation protocol on the growth and proliferation of PC-12 cells free floating in growth 
media. 
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The results of our research will increase our understanding of the effects of magnetic 
fields used in TMS at the cellular level, increase the knowledge of the underlying mechanisms 
behind TMS, and contribute the ongoing research into treatments for PD and AD. 
Experiment Procedure 
Experimental Timeline 
The chart in Fig. 1 shows the timeline followed during the experimental trials. 
 
Fig. 1. The major events of the experimental trials at their respective time points during each trial. 
Cell Culture 
The PC-12 cells were cultured in 1640 RPMI [+ L-Glutamine] medium supplemented 
with 10% horse serum, 5% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 
U/ml), maintained at 37 °C in a humidified atmosphere of 5% CO2. 
Magnetic Stimulation 
A commercially available Magstim 2002 monophasic stimulator was used along with a 
commercially available D702 figure-8 coil from the Magstim company to apply magnetic 
stimulation to the cells. The stimulator was set at 100% power output for the stimulation 
sessions. The cells received 150 pulses in single 12 min session. The pulse rise time was ~100 µs 
with a duration of 1 ms. The frequency of the stimulation pulse was 1 kHz. 
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Measured Magnetic Fields 
The magnetic field strength (H) generated by the coil was measured using a Gaussmeter 
and an axial Hall probe. The placement of the Hall probe was 20 mm from the coil. This is the 
distance between the coil and the cells in the wells during the experiments. The maximum field 
strength was measured multiple times and averaged. The average measured peak H field for the 
D702 figure-8 coil was calculated to be 0.559 T (0.445 MA/m). 
Stimulation Schematic 
The placement of the well plates that held the cells during the experiments with respect to 
the stimulation coil is shown in Fig. 2. 
 
Fig 2. Location of the cells in the well plates with respect to the TMS coil during stimulation sessions. 
Cell Counting 
At each time point, a single well from each of the well plates, non-stimulated and 
stimulated were counted. The cells were transferred to a 15 ml test tube and the well was rinsed 
with buffer solution 3x with the rinse added to the tube containing the cells. Then the cells were 
isolated from the media via centrifuging. Next, an EDTA-Trypsin (0.25%) solution was used to 
break up cell clumps into single cells. Finally, an Invitrogen Countess cell counter was used to 
count two samples from each well and the results were averaged. 
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Results 
Representative images in Fig. 3 show the morphology comparison between the stimulated 
groups and the non-stimulated groups. The plots in Fig. 4 show the cell numbers that were 
counted at each time point during the trials. 
 
Fig. 3. Images of PC-12 cell cultures during various time-points of the experiment showing no 
morphological difference between the stimulated and non-stimulated groups. 
 
Fig. 4. Non-stimulated and stimulated PC-12 cell proliferation over 8 day time period. Cells were seeded 
in wells at 0 h time point. Magnetic stimulation was applied at 24 h time point. 
80 
Statistical Analysis 
Fig. 5 shows the results of the analysis of the stimulated compared with non-stimulated 
cell groups.  
 
Fig. 5. The analysis shows that the groups are statistically the same. No change in proliferation rate for 
the stimulated group when compared to the non-stimulated group.  
Cell Viability 
Trypan Blue staining method was used to check cell viability at the 216 h time point. All 
replicates were tested. The results in Table 1 show that both groups had very high viability and 
were statistically the same. 
Table 1. Average cell viability for all replicates using Trypan Blue staining. 
Cell Group Cell Viability 
Non-Stimulated 96 ± 3% 




The identical protocol of magnetic field stimulation that increases proliferation of N27 
adherent neuronal cells was shown not to increase the proliferation of PC-12 non-adherent 
neuronal cells. The magnetic field stimulation did not affect PC-12 cell viability as shown by 
Trypan Blue viability testing. Nor did the stimulation affect PC-12 cell morphology. 
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Abstract 
Transcranial Magnetic Stimulation (TMS) is a U.S. Food and Drug Administration 
(FDA) approved method for treating major depressive disorder and obsessive-compulsive 
disorder. The effect of time dependent magnetic fields on the brain has yet to be fully 
investigated at the cellular level. Our research investigated the effects of pulsed magnetic fields 
generated by TMS stimulators on the growth of neurite extensions of Nerve Growth Factor 
(NGF) differentiated PC-12 neuronal cells. A predetermined number of magnetic pulses were 
applied within a short time period using a Magstim 2002 monophasic stimulator with the 
Magstim D702 figure-eight dual 70 mm high-focality coil. The stimulation session was repeated 
daily for the duration of the experimental trials. 
When TMS is applied to a patient, neurites will experience the applied field according to 
their orientation within the brain. Our research probed the consequence of applying the magnetic 
field in different orientations with respect to the growth surface plane of neurites. Each 
stimulated cell group had a control group that was subjected to all the same experimental steps 
except magnetic stimulation.  
Results showed that pulsed magnetic stimulation applied orthogonal to the growth 
surface increases the average length of neurite extensions on PC-12 cells. Our current work is 
83 
exploring the effects of magnetic stimulation on neurite growth when the field is applied parallel 
to the growth surface as well as at different orientation angles with respect the cell. The results of 
this work will increase our understanding of the effects of magnetic fields at the cellular level as 
well as the underlying mechanisms behind TMS. 
Introduction 
Transcranial Magnetic Stimulation (TMS) is approved by the U.S. Food and Drug 
Administration (FDA) as a method for treating major depressive disorder (MDD) and obsessive-
compulsive disorder (OCD). However, the effect of TMS type fields on the brain has yet to be 
fully investigated at the cellular level. Our research investigated the effects of monophasic pulsed 
magnetic fields generated by a TMS stimulator on the growth of neurite extensions of PC-12 
cells stimulated with nerve growth factor beta (NGFβ). 
When TMS is applied to a patient, neurites will experience the applied field according to 
their orientation within the brain. Our research probed the consequence of applying the magnetic 
field in different orientations with respect to the growth surface plane of the neurites. Each 
stimulated cell group had a control group that was subjected to all the same experimental steps 
except magnetic stimulation. 
Previous work showed that a single session of stimulation applied orthogonal to the 
growth surface increased the average length of neurite extensions on PC-12 cells. Our current 
work is exploring the effects of multiple stimulation sessions on neurite growth when the field is 
applied orthogonal and when applied parallel to the growth surface. 
Experiment Procedure 
Experiment Timeline 
The chart in Fig. 1 shows the timeline followed during the experimental trials. 
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Fig. 1. The major events of the experimental trials at their respective time points during each trial. 
Cell Preparation 
The PC-12 cells were cultured in 1640 RPMI [+ L Glutamine] medium supplemented 
with 10% horse serum, 5% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 
U/ml), maintained at 37 °C in a humidified atmosphere of 5% CO2. The extracellular matrix used 
was Matrigel (50 μg/ml diluted 1:8 with 1640 RPMI). Prior to seeding the cells, the Matrigel was 
applied to bottom of the wells, then incubated at room temperature for 60 min. The cells were 
seeded with 1640 RPMI [+ L Glutamine] medium supplemented with 1% horse serum, penicillin 
(100 U/ml), and streptomycin (100 U/ml), and 50 ng/ml NGFβ. 
Magnetic Stimulation 
A commercially available Magstim 2002 monophasic stimulator was used along with a 
commercially available D702 figure-8 coil from the Magstim company to apply magnetic 
stimulation to the cells. The stimulator was set at 100% power output for the stimulation 
sessions. The cells received 150 pulses in single 12 min session. The pulse rise time was ~100 µs 
with a duration of 1 ms. The frequency of the stimulation pulse was 1 kHz. Stimulation sessions 
were repeated every 24 hours for a total of 4 stimulation sessions per trial. 
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Measured Magnetic Fields 
The magnetic field strength (H) generated by the coil was measured using a Gaussmeter 
and an axial Hall probe. The placement of the Hall probe was 12 mm from the. This is the 
distance between the coil and the cells in the wells during the experiments. The maximum field 
strengths were measured multiple times and averaged. The averaged measured peak H field for 
the D702 figure-8 coil was calculated to be 0.509 T (0.405 MA/m). 
Stimulation Schematic 
The placement of the well plates that held the cells during the experiments with respect to 
the stimulation coil is shown in Fig. 2. 
 
Fig 2. Location of the cells in the well plates with respect to the TMS coil during stimulation sessions. 
Method of Analysis 
Image J software was used to measure the angle of growth of the neurite extensions from 
the main cell body with respect to the direction of the applied magnetic field. Three types of 
measurements were taken of each extension as described in Fig. 3.  Only extensions ≥ 11 µm 
were considered for taking measurements and counting.  
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Fig. 3. Examples of how the neurite extensions were measured using Image J software. Measurements in 
a straight line from the base of the extension to the tip of the longest branch. Measurements of the entire 
length of the extension. Measurements of the angle of the primary branch of the extension as it grows 
from the main cell body. 
Results 
Plots comparing the lengths of the neurite extensions of the stimulated cells with the non-
stimulated cells are shown for the groups stimulated orthogonally to the substrate in Fig. 4, and 
parallel to the substrate in Fig 5.  
 
Fig. 4. Average neurite lengths of PC-12 cells stimulated orthogonally to the plane of cell growth. 
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Fig. 5. Average neurite lengths of PC-12 cells stimulated parallel to the plane of growth. 
Statistical Analysis 
The error bars on the chart in Fig. 4 and Fig. 5 are the standard error of the means. A two-
tailed t-Test was applied for the 95% confidence interval to determine if there is a significant 
difference between each pair (non-stimulated and stimulated) at 120 hours. 
Discussion 
Multiple pulsed stimulation sessions from a production TMS stimulator resulted in a 
significant reduction in average neurite length for the stimulated group when the field was 
applied orthogonal to the plane of growth.  However, the stimulation protocol did not result in a 
significant difference between non-stimulated and stimulated groups when the field was applied 
parallel to the plane of growth. Nor did the pulsed stimulation protocol result in a significant 
difference of extension branching. 
Further analysis of the direction of neurite growth of the primary neurites, and the 
direction of a straight line base-to-tip, with respect to the applied field is currently under way.  
Acknowledgment 
Funded by the National Science Foundation and partially funded by the Stanley Chair in 
Interdisciplinary Engineering at Iowa State University. 
88 
References 
[1] M. Isserles et al., “Effectiveness of deep transcranial magnetic stimulation combined with a 
brief exposure procedure in post-traumatic stress disorder-a pilot study,” Brain Stimul. 
6(3), 377–383 (2013).  
[2] “PC-12 ATCC ® CRL-1721TM Rattus norvegicus adrenal gland pheoc.” [Online]. 
Available: https://www.atcc.org/products/all/CRL-1721.aspx. [Accessed: 10-Apr-2018]. 
[3] The Magstim Company Limited, “Magstim 2002 Operating Manual (P/N 3001-23-04),” 28 
(March 2005) 
[4] L. J. Crowther, R. L. Hadimani, and D. C. Jiles, “Effect of anatomical brain development on 
induced electric fields during transcranial magnetic stimulation,” 50(11) (2014). 
[5] Joe Boldrey, Xiaojing Zhong, Long Que, Ian Schneider, David Jiles, "The Influence of 
Pulsed Magnetic Fields on NGF Differentiated PC-12 Neuronal Cells", Minnesota 
Neuromodulation Symposium, Minneapolis, USA, April 12-13, 2018 
89 
CHAPTER 9.    EFFECTS OF MAGNETIC STIMULATION ON THE 
PROLIFERATION OF DOPAMINERGIC NEURONAL CELLS GROWN IN 
EXTRACELLULAR MATRIX 
Joseph Boldrey1, Xiaojing Zhong1, Long Que1, Ian Schneider2, and David Jiles1 
 
1Department of Electrical and Computer Engineering, Iowa State University 
2Department of Chemical and Biological Engineering, Iowa State University 
 
Modified from a presentation given at the 2018 IEEE Magnetics Society Intermag Conference, Singapore 
 
Abstract 
Transcranial Magnetic Stimulation (TMS) is a neuromodulation technique which is 
capable of non-invasively activating the neurons in the brain. TMS has been an approved method 
of treatment for major depressive disorders by the U.S. Food and Drug Administration (FDA) 
since 2008. The major principle in TMS is electromagnetic induction. The time varying magnetic 
field generated by the TMS stimulator induces an electric field in conductive brain tissues which 
activates neurons by depolarization. However, limited studies have reported the effects of the 
magnetic fields used in TMS on individual neurons and in cell cultures, especially on neuronal 
cells grown in a three-dimensional extracellular matrix (3D ECM). The main function of a 3D 
ECM is to provide the biochemical and structural support to the surrounding cells that is found in 
vivo. The protein collagen is the major component of the ECM that plays an important role in 
giving cells strength and structural integrity. Hyaluronan is a polysaccharide found in the ECM 
of all vertebrates. It is known to provide support and protection to the cells within the ECM. 
Poly-D-Lysine (PDL) is a positively charged amino acid polymer used to help cells bind to 
substrates such as glass and plastic. 
Based on these theories, we investigated the effects of magnetic fields generated by a 
monophasic TMS stimulator using a 90 mm circular coil on the N27 rat dopaminergic neuronal 
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cell line grown on two-dimensional (2D) and in three-dimensional (3D) ECMs. In our 
experiments, collagen-coated functionalized glass cover slips and PDL coated cover slips were 
used as 2D ECM for cell growth. Images of both, stimulated group, and non-stimulated group, 
were captured at five time points from the stimulation time (0 hour) to 72 hours. Cells were 
counted, averaged, and plotted. The results of our experiments showed that the magnetic 
stimulation decreased the growth rate of the N27 cells in comparison to the non-stimulated 
control group. However, it was observed that the collagen coating helped the cells to be more 
resistant to this negative effect caused by magnetic stimulation. We concluded that the magnetic 
stimulation used in our study decreased the proliferation of N27 dopaminergic neuronal cells and 
that collagen plays a role in protecting the cells from adverse effects of strong magnetic fields. 
Experiments currently underway are studying the effects that magnetic fields have on N27 cells 
within 3D ECM of collagen and 3D ECM of collagen/hyaluronan.  
Introduction 
Transcranial Magnetic Stimulation (TMS) is a neuromodulation technique which is 
capable of non-invasively activating the neurons in the brain. TMS has been an approved method 
of treatment for major depressive disorders by the U.S. Food and Drug Administration (FDA) 
since 2008. However, limited studies have reported the effects of the magnetic fields used in 
TMS on individual neurons and in cell culture. This study investigated the effects of time-
dependent magnetic fields generated by a monophasic TMS stimulator using a 70 mm figure-of-
eight dual coil on the N27 rat dopaminergic neuronal cell line grown on two-dimensional (2D) 
extracellular matrix (ECM). The N27 cell line is widely used in biomedical studies as a model 




The chart in Fig. 1 shows the timeline followed during the experimental trials. 
 
Fig. 1. The major events of the experimental trials at their respective time points during each trial. 
2D Extracellular Matrix 
Collagen coated functionalized glass cover slips and poly-D-lysine (PDL) coated glass 
cover slips were used as the 2D ECM for cell growth. 
Cell Culture 
Rat mesencephalic cells (N27) were grown in RPMI medium supplemented with 10% 
fetal bovine serum, 1% L-glutamine, penicillin (100 U/ml), and streptomycin (100 U/ml), 
maintained at 37 °C in a humidified atmosphere of 5% CO2. 
Magnetic Stimulation 
A commercially available Magstim 2002 monophasic stimulator was used along with a 
commercially available D702 figure-8 coil from the Magstim company to apply magnetic 
stimulation to the cells. The stimulator was set at 100% power output for the stimulation 
sessions. The cells received 150 pulses in single 12 min session. The pulse rise time was ~100 µs 
with a duration of 1 ms. The frequency of the stimulation pulse was 1 kHz. 
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Measured Magnetic Fields 
The magnetic field strength (H) generated by the coil was measured using a Gaussmeter 
and an axial Hall probe. The placement of the Hall probe was 20 mm from the coil. This is the 
distance between the coil and the cells in the wells during the experiments. The maximum field 
strength was measured multiple times and averaged. The average measured peak H field for the 
D702 figure-8 coil was calculated to be 0.559 T (0.445 MA/m). 
Stimulation Schematic  
The placement of the well plates that held the glass cover slips during the experiment 
trials with respect to the stimulation coil is shown in Fig. 2. 
 
Fig 2. Location of the glass coverslips used for growing the N27 cells with respect to the TMS coil during 
stimulation sessions. 
Results 
Representative images in Fig. 3 show no difference in morphology for the cells grown on 
poly-D-lysine compared to the cells grown on collagen. The numbers of cells counted at each 
time point during the trials are plotted in Fig. 4. 
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Fig. 3. Images of N27 cell cultures during various time-points of the experiment showing no 
morphological difference between cells grown on poly-D-lysine and collagen ECMs, respectively. 
 
 
Fig. 4. Comparison of cell numbers with respect to time. Magnetic stimulation applied at 24hr time point 
after seeding cells on collagen and PDL ECMs, respectively. 
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Statistical Analysis 
Fig. 5 shows the analysis of the cells (stimulated compared with non-stimulated) using 
the figure-8 coil for stimulation while being grown in the different ECMs.   
 
Fig. 5. The groups that received magnetic stimulation show an increase in proliferation rate compared to 
the groups that did not receive magnetic stimulation.  This increase occurred on both ECMs, collagen and 
poly-D-lysine.  
Conclusion 
Single-phase time-dependent magnetic field stimulation increases growth and 
proliferation of N27 neuronal cells on collagen and on poly-D-lysine coated 2D extracellular 
matrices (ECM). Direct observation of the cell cultures show that the N27 cells grow better on 
the collagen coated surface than the PDL coated surface. The cells attach to and spread more on 
the collagen. This is an indication of a better growth environment. Future experiments will study 
the effects in 2.5 dimensions and 3 dimensions ECMs. 
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CHAPTER 10.    GENERAL CONCLUSION 
In this research, two modeling techniques were used to investigate the effects of magnetic 
fields generated during TMS treatment of neuronal cells. 
A computer model was used to investigate the variability of brain-scalp distance (BSD) 
on the brain’s response to TMS from the QBC and the FoE coils.  It was concluded that the EMAX 
in the brain induced by the QBC decreases with BSD. This result was also found using the FoE 
coil. The R-value statistical correlation of EMAX to the BSD for the two coils are 0.4293 for the 
QBC and 0.4141 for the FoE coil. These results confirm that the BSD has a moderate correlation 
to the EMAX regardless of the coil used. However, there is no significant correlation between 
BSD and the V-Half (the parameter for focality). This result indicates that the advantages of the 
increased focality of the QBC over the FoE are applicable over a range of subjects with differing 
BSD. 
Two biological models were used to investigate various aspects of neuronal cells’ 
response, at the cellular level, to magnetic fields generated during TMS.  Results show that 
monophasic TMS fields, at sufficient intensity, increase the proliferation rate of N27 neuronal 
cells. This increase occurs on collagen and on poly-D-lysine ECMs. By modulating the H field, a 
threshold of the sufficient intensity is shown to exist between 0.4728 T and 0.5593 T. The 
identical protocol of magnetic field stimulation that increases proliferation of N27 adherent 
neuronal cells was shown not to increase the proliferation of PC-12 non-adherent neuronal cells. 
The magnetic field stimulation did not affect the N27 cell viability as shown by the calcein AM 
and propidium iodide fluorescence microscopy testing. Nor did the stimulation affect PC-12 cell 
viability, as shown by the Trypan Blue viability testing. Empirical observation showed that 
neither cell line’s morphology was affected by the magnetic stimulation. It was shown that 
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monophasic TMS fields applied to PC-12 cells in multiple stimulation sessions resulted in a 
significant reduction in average neurite length for the group that was stimulated with the H field 
orthogonal to the plane of growth.  However, the stimulation protocol did not result in a 
significant difference in neurite length when the H field was applied parallel to the plane of 
growth. Regardless of the direction of applied field, the results show no significant difference 
between the stimulated and non-stimulated groups when measuring directional bias of new 
neurites, directional bias of overall neurite growth, or extension branching for PC-12 cells. 
The modeling techniques shown in this paper demonstrate how computer models and 
biological models can be used to increase our understanding of the mechanisms behind the 
brain’s response to the magnetic fields applied during TMS.  
